Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2020 Annual Meeting | P6 - Poster Session 6

Monday 04/27/20
12:00 PM - 01:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Research Methodology, Education, and History, Aging, Dementia, Cognitive, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-ophthalmology/Neuro-otology
0.00 credit
Event Timeline
12:00 PM - 01:00 PM Abstract 9-001 - Analysis of Reported Deaths While Exposed to Disease-Modifying Therapies for Multiple Sclerosis
Sam Hooshmand, DO
12:00 PM - 01:00 PM Abstract 9-002 - In depth analysis of T cells in multiple sclerosis patients after treatment with Cladribine
Felix Marsh-Wakefield
12:00 PM - 01:00 PM Abstract 9-003 - Absolute Lymphocyte Counts Are Not a Biomarker of Clinical Response in Patients Treated With Delayed-Release Dimethyl Fumarate
Erin Longbrake, MD, PhD, FAAN
12:00 PM - 01:00 PM Abstract 9-004 - Dimethyl fumarate treatment alters T cell metabolism in multiple sclerosis
Luisa Hildegard Klotz, MD
12:00 PM - 01:00 PM Abstract 9-005 - Change in cognitive processing speed is associated with cortical grey matter and thalamic volume loss in patients with relapsing-remitting multiple sclerosis
Ralph H. B. Benedict, PhD
12:00 PM - 01:00 PM Abstract 9-006 - Efficacy and safety of fingolimod and dimethyl fumarate for management of multiple sclerosis: A single center retrospective study.
Anza Memon, MD, FAAN
12:00 PM - 01:00 PM Abstract 9-007 - Cerebral Bioavailability of Cladribine : Influence of Metabolism and Mechanism of Transport across Brain Barriers
Nathalie Strazielle
12:00 PM - 01:00 PM Abstract 9-008 - Serum Ig Levels and Risk of Serious Infections by Baseline Ig Quartile in the Pivotal Phase III Trials and Open-Label Extensions of Ocrelizumab in Multiple Sclerosis
Amit Bar-Or, MD, FRCPC
12:00 PM - 01:00 PM Abstract 9-009 - Improvement in Patient-Reported SymptoMScreen Scores Among Ocrelizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis: 1-Year Results From the CASTING Clinical Trial
Ilya Kister, MD, FAAN
12:00 PM - 01:00 PM Abstract 9-010 - It's Not Always An Infection: Pyoderma Gangrenosum of the Urogenital Tract in Two Patients with Multiple Sclerosis Treated with Rituximab
Erica Hailey Parrotta, DO
12:00 PM - 01:00 PM Abstract 9-011 - Immunomodulatory Effects of DMF Treatment on the Peripheral Lymphocyte Compartment: A Focus on Older MS Patients
Fabrizio Giuliani, MD
12:00 PM - 01:00 PM Abstract 9-012 - Overall Safety and Efficacy Through 10 Years of Treatment with Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis
Ralf Gold, MD
12:00 PM - 01:00 PM Abstract 9-013 - Interim analysis of peginterferon beta-1a in the breast milk of lactating patients with multiple sclerosis
Maria K. Houtchens, MD
12:00 PM - 01:00 PM Abstract 9-014 - Transition to non-active secondary progressive multiple sclerosis (SPMS) after up to 9.5 years of natalizumab treatment in the real-world TYSABRI Observational Program (TOP)
Ludwig Kappos, MD, FAAN
12:00 PM - 01:00 PM Abstract 9-015 - Multiple sclerosis-like CNS inflammation following allogeneic haematopoietic stem cell transplantation treated with a ‘domino’ autologous haematopoietic stem cell transplantation
Joyutpal Das, MBBS
12:00 PM - 01:00 PM Abstract 9-016 - In Vitro Assessment of the Binding and Functional Reponses of Ozanimod and Its Circulating Metabolites Across Human Sphingosine 1-Phosphate Receptors
Julie Selkirk
12:00 PM - 01:00 PM Abstract 9-017 - Effects of Ozanimod on Information Processing Speed: Findings From the Phase 3 SUNBEAM and DAYBREAK Extension Trials
John DeLuca, PhD, ABPP
12:00 PM - 01:00 PM Abstract 9-018 - Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
Stephen L. Hauser, MD
12:00 PM - 01:00 PM Abstract 9-019 - Severe Reactivation of Rheumatic Cardiopathy During Treatment with Ocrelizumab.
Luis Hernandez-Echebarria
12:00 PM - 01:00 PM Abstract 9-020 - Rapid onset drug induced neutropenia associated with Ocrelizumab in Multiple Sclerosis
Varun Kumar Pala, MD
12:00 PM - 01:00 PM Abstract 9-021 - Ocrelizumab real-world safety in the treatment of multiple sclerosis (MS): Differences between investigator-reported and patient-reported safety
Jost Leemhuis
12:00 PM - 01:00 PM Abstract 9-022 - Safety and Effectiveness of Dimethyl Fumarate Maintained Over 4 Years in Multiple Sclerosis Patients Treated in Routine Medical Practice
Konstantin E. Balashov, MD, PhD, FAAN
12:00 PM - 01:00 PM Abstract 15-001 - Validation of a Live Cell-Based Assay For Antibodies to Clustered Acetlycholine Receptor Antibodies in Myasthenia Gravis
Anna Fronda
12:00 PM - 01:00 PM Abstract 15-002 - Validation of a Surface Plasmon Resonance Assay for the Diagnostic Detection and Characterization of Muscle-specific Kinase (MuSK) Antibodies in Myasthenia Gravis (MG) Patients
Ebrima Gibbs, Bsc,BMLSc,MSc
12:00 PM - 01:00 PM Abstract 15-003 - Use of Subcutaneous Immunoglobulin in Stiff Person Syndrome
Salman Aljarallah, MD
12:00 PM - 01:00 PM Abstract 15-004 - Circulating B Cell Subsets and Cytokine Gene Expression Levels in Peripheral Blood and Skin Biopsy in Chronic Inflammatory Demyelinating Polyneuropathy
Ayse Nur Ozdag Acarli
12:00 PM - 01:00 PM Abstract 15-005 - Presentation and Long-term Neurologic and Neurodevelopmental Profiles in Pediatric Patients with Febrile Infection-Related Epilepsy Syndrome (FIRES): A Single Institution Review
Kristen Fisher, DO
12:00 PM - 01:00 PM Abstract 15-006 - Feasibility & Safety of Plasma Exchange in Pediatric Neuro-immunology: A Single Center Experience
Padmavati Rajdatta Eksambe, MD
12:00 PM - 01:00 PM Abstract 15-007 - Presence of P/Q Voltage-gated Calcium Channel (VGCC) Antibodies in Pediatric Autoimmune Encephalitis
Kristen Fisher, DO
12:00 PM - 01:00 PM Abstract 15-008 - Pediatric anti-NMDA Receptor Encephalitis
Lydia Robinson Marcus, MD
12:00 PM - 01:00 PM Abstract 15-009 - Performance Evaluation of a Radioimmunoprecipitation Assay for the Detection of N-Type Voltage-gated Calcium Channel Antibodies in Patient and Control Groups
Thomas Raymond Haven, PhD
12:00 PM - 01:00 PM Abstract 15-010 - Improving the Identification and Diagnosis of Autoimmune Encephalitis Patients: A Departmental Quality Improvement Project.
Raffaella Umeton, MD
12:00 PM - 01:00 PM Abstract 15-011 - Broken heart in Morvan’s syndrome
Amit Shankar Singh, MD
12:00 PM - 01:00 PM Abstract 15-012 - Neuronal uptake, antibody binding, and injury by anti-Ma2 antibodies in organotypic cultures of rat brain: a possible role for anti-Ma2 antibody in production of neurological disease
Jonathan Ross Galli, MD
12:00 PM - 01:00 PM Abstract 3-001 - Minimal Clinically Important Difference in AIMS Score Based on Clinical and Patient Global Impression of Change in Patients With Tardive Dyskinesia Treated With Deutetrabenazine
Hadas Barkay
12:00 PM - 01:00 PM Abstract 3-002 - Analyzing Sex Differences in Huntington’s Disease using Enroll-HD
Erin Furr-Stimming, MD, FAAN
12:00 PM - 01:00 PM Abstract 3-003 - Patient and Physician Perspectives on the Care and Assistance Needs in Huntington’s Disease (HD)
Alex Exuzides
12:00 PM - 01:00 PM Abstract 3-004 - Using Functional Status to Aid Interpretation of Composite Unified Huntington’s Disease Rating Scale (cUHDRS) Scores in Patients with Huntington’s Disease (HD)
Jeffrey D. Long
12:00 PM - 01:00 PM Abstract 3-005 - Long-term Safety and Efficacy of Deutetrabenazine in Younger and Older Patients With Tardive Dyskinesia
Martha Sajatovic, 5110
12:00 PM - 01:00 PM Abstract 3-006 - GEORGE® – The First Smartphone Application for Huntington Disease: A Pilot Study
Jamie Lynn Adams, MD
12:00 PM - 01:00 PM Abstract 3-007 - Discovering Dominant Features Associated with Disease Progression in Huntington’s Disease (HD): A Data-driven Approach Using the Enroll-HD Database
Naghmeh Ghazaleh
12:00 PM - 01:00 PM Abstract 3-008 - Treatment Responses with Long-Term Valbenazine in Patients with Tardive Dyskinesia
Carlos Singer, MD
12:00 PM - 01:00 PM Abstract 3-009 - Impact of Caring for Patients with Huntington’s Disease (HD) on Work Status
Alex Exuzides
12:00 PM - 01:00 PM Abstract 3-010 - Chart Extraction/Clinician Survey Shows Symptom Impact and Favorable Treatment Outcomes with VMAT2 Inhibitors in Patients with Tardive Dyskinesia
Chuck Yonan
12:00 PM - 01:00 PM Abstract 3-011 - Comorbidities and Medications in Huntington’s Disease, Parkinson’s Disease and the General Population in a US Claims Database
Edward J. Wild, PhD, MBBS, MRCP
12:00 PM - 01:00 PM Abstract 3-012 - Late-onset Huntington’s Disease: A Retrospective Review of 38 Cases
Kristina Hart, DO
12:00 PM - 01:00 PM Abstract 3-013 - Clinical correlates of Body Mass Index in Mexican patients with Huntington’s disease
Cynthia Lopez-Botello
12:00 PM - 01:00 PM Abstract 3-014 - Parkinsonism secondary to use of valbenazine and reversal with the addition of levodopa: A Case Report
Rani *use 291581 Vasireddy, MD
12:00 PM - 01:00 PM Abstract 3-015 - Chorea as an Uncommon Adverse Reaction to Ertapenem
Shweta Varade, MD
12:00 PM - 01:00 PM Abstract 12-001 - Using Machine Learning to Augment Differentiation of Epileptic and Psychogenic Non-Epileptic Seizures Recorded with sEMG
Damon Philip Cardenas, PhD
12:00 PM - 01:00 PM Abstract 12-002 - Accuracy of Automated Machine Learning Software in Identifying EEGs with Prolonged Seizures
Rebecca T. Hsu, MD
12:00 PM - 01:00 PM Abstract 12-003 - Indication and Yield of Ambulatory EEG Recordings
Yara Mikhaeil-Demo, MD
12:00 PM - 01:00 PM Abstract 12-004 - Effects of an Evidence-Based Continuous EEG Triage Protocol on Seizure Detection in Hospitalized Adults: A Quality Improvement Analysis
Jessie Jacobson, DO
12:00 PM - 01:00 PM Abstract 12-005 - Introducing New Technologies in a Training Program: Lessons from Implementing a Stat Electroencephalography Program at a Major Academic Medical Center
Erin Barnes, MD
12:00 PM - 01:00 PM Abstract 12-006 - Intra-burst Theta During Burst-suppression Pattern in Comatose Post-cardiac Arrest Patients Correlates with Outcome; a Prospective Study
Ryka Sehgal, MD
12:00 PM - 01:00 PM Abstract 12-007 - Prevalence of Pulmonary Diseases in Patients with a History of Epilepsy/Seizures
Khalid I. El-Salem, MD, FAAN
12:00 PM - 01:00 PM Abstract 12-008 - Evaluation of Epilepsy Classification and Optimal Treatment Plan in Post-Stroke Epilepsy: A Single Center Experience
Lilly Fagatele
12:00 PM - 01:00 PM Abstract 12-009 - Patterns of Referral to a Comprehensive Epilepsy Program Iin An Urban Tertiary Care Center
Meghana Kinariwala, MD
12:00 PM - 01:00 PM Abstract 12-010 - Long term outcome of Epilepsy camps in rural India
Nirmal Surya, MD, DNB, FAAN
12:00 PM - 01:00 PM Abstract 12-011 - Evaluating a Data Quality and Safety Protocol for Epilepsy Monitoring Units: Two Years of Experience.
Marino Bianchini
12:00 PM - 01:00 PM Abstract 12-012 - Prevalence and Risk Factors for Post-Stroke Epilepsy
sofia farina
12:00 PM - 01:00 PM Abstract 6-001 - Functional studies and therapeutic strategies for SLC20A2-associated primary brain calcification
Isao Hozumi, MD, PhD
12:00 PM - 01:00 PM Abstract 6-002 - L-Methylfolate Calcium Supplementation in Adolescents and Children: A Retrospective Analysis
Michelle Rainka, PharmD
12:00 PM - 01:00 PM Abstract 6-003 - Long-Term Impact of Inotersen on Health-Related Quality-of-Life for Hereditary Transthyretin Amyloidosis with Polyneuropathy: NEURO-TTR Open-Label Extension at Two Years
Aaron Yarlas, PhD
12:00 PM - 01:00 PM Abstract 6-004 - A Potential Cure in Adult Onset Subacute Sclerosing Panencephalitis
Samhita Panda, MD, DM
12:00 PM - 01:00 PM Abstract 6-005 - The role of different therapeutic approaches to neurological Wilson´s disease in homozygotic twins with clinical phenotypic variability: case report and literature review
Sara Samadzadeh
12:00 PM - 01:00 PM Abstract 6-006 - Serotonin Receptor Activity Profiles for Nine Commercialized Ergot Alkaloids Correspond to Known Risks of Fibrosis and Hallucinations
Robert Fishman, MD
12:00 PM - 01:00 PM Abstract 6-007 - Longer-term Treatment With Nusinersen: Results in Later-onset Spinal Muscular Atrophy From the SHINE Study
Claudia A. Chiriboga, MD, FAAN
12:00 PM - 01:00 PM Abstract 6-008 - Responder Analysis for the Modified Neuropathy Impairment Score + 7 and the Norfolk-Quality of Life-Diabetic Neuropathy Questionnaire in Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy
Aaron Yarlas, PhD
12:00 PM - 01:00 PM Abstract 6-010 - Safety Profile of Nusinersen in Presymptomatic and Infantile-Onset Spinal Muscular Atrophy (SMA): Interim Results From the NURTURE and ENDEAR-SHINE Studies
Basil T. Darras, MD
12:00 PM - 01:00 PM Abstract 6-011 - Perampanel for Sporadic Amyotrophic Lateral Sclerosis
Hitoshi Aizawa
12:00 PM - 01:00 PM Abstract 6-012 - Longer-term Experience with Nusinersen in Teenagers and Young Adults with Spinal Muscular Atrophy: Results from the CS2/CS12 and SHINE Studies
John W. Day, MD, PhD
12:00 PM - 01:00 PM Abstract 7-001 - 10-Year Cost-effectiveness Analyses of Fremanezumab Compared to Erenumab as Preventive Treatment in Episodic Migraine for Patients With Inadequate Response to Prior Preventive Treatments
Lee Smolen
12:00 PM - 01:00 PM Abstract 7-002 - Comparative Efficacy and Safety of Rimegepant Versus Ubrogepant and Lasmiditan for Acute Treatment of Migraine: A Network Meta-analysis (NMA)
Karissa Johnston
12:00 PM - 01:00 PM Abstract 7-003 - Rimegepant Has No Clinically Relevant Effect on ECG parameters at Therapeutic and Supratherapeutic Doses: A Thorough QT Study Versus Placebo and Moxifloxacin in Healthy Subjects
Michael Hanna, PhD
12:00 PM - 01:00 PM Abstract 7-004 - OnabotulinumtoxinA Treatment Improved Health-Related Quality of Life in Adults with Chronic Migraine: Results from a Prospective, Observational Study (PREDICT)
Guy Boudreau
12:00 PM - 01:00 PM Abstract 7-005 - Rimegepant 75 mg is Effective for the Acute Treatment of Migraine Regardless of Attack Frequency: Results From 3 Phase 3 Trials
Morris Levin, MD, FAAN
12:00 PM - 01:00 PM Abstract 7-006 - Rimegepant 75 mg Provides Early and Sustained Relief of Migraine With a Single Dose: Results from 3 Phase 3 Clinical Trials
Jelena M. Pavlovic, MD, PhD
12:00 PM - 01:00 PM Abstract 7-007 - Impact of Fremanezumab on Migraine-associated Symptoms in Patients With Episodic and Chronic Migraine and Documented Inadequate Response to 2-4 Classes of Migraine Preventive Medications During the Open-label Period of the Phase 3b FOCUS Study
Laszlo Mechtler, MD, FAAN, FASN
12:00 PM - 01:00 PM Abstract 7-008 - Changes in Depression and Anxiety in a Randomized, Double-blind, Placebo-controlled Study of Galcanezumab in Adults with Treatment-resistant Migraine: Results from the CONQUER Study
Morris Maizels
12:00 PM - 01:00 PM Abstract 7-009 - Lasmiditan in Patients with Common Migraine Comorbidities: A Post hoc, Safety, and Efficacy Analysis of Two Phase 3 Randomized Clinical Trials
David Clemow
12:00 PM - 01:00 PM Abstract 7-010 - Impact of Fremanezumab on Headache-related Disability in Patients With Migraine and Documented Inadequate Response to 2-4 Classes of Migraine Preventive Medication Classes in the Open–label Extension of the Phase 3b FOCUS Study
Amaal J. Starling, MD, FAAN
12:00 PM - 01:00 PM Abstract 7-011 - Is Botulinum Toxin Effective in Treating Menstrually Related Migraine?
Brin Freund, MD
12:00 PM - 01:00 PM Abstract 7-012 - Efficacy Is Maintained With Long-term Intermittent Use of Ubrogepant for the Acute Treatment of Migraine
Joel M. Trugman, MD, FAAN
12:00 PM - 01:00 PM Abstract 7-013 - High Frequency Episodic Migraine Shift to Low Frequency Episodic Migraine in Patients Treated with Galcanezumab
Eric J. Eross, DO
12:00 PM - 01:00 PM Abstract 1-001 - Nerve Conduction Studies in Familial Dysautonomia
Joel Gutierrez, MD
12:00 PM - 01:00 PM Abstract 1-002 - Impact of Patisiran, an RNAi Therapeutic, on Orthostatic Intolerance in Patients with Hereditary Transthyretin-Mediated Amyloidosis
Peyton Meyer
12:00 PM - 01:00 PM Abstract 1-003 - Establishment of Normative Data for Cardiovascular Autonomic Function Tests in Indian Population
Vineeth Jaison, MD, MBBS, DM
12:00 PM - 01:00 PM Abstract 1-004 - Autonomic Dysfunction in Diabetic and Non-diabetic Lumbosacral Radiculoplexus Neuropathy
Kamal Shouman, MD
12:00 PM - 01:00 PM Abstract 1-005 - Association of GAD-65 Antibodies with Autonomic Dysfunction in non-Type I diabetic patients
Nina Bozinov, MD
12:00 PM - 01:00 PM Abstract 1-006 - The V122I Mutation in Hereditary Transthyretin-Mediated Amyloidosis is Significantly Associated with Polyneuropathy
Paul Nioi
12:00 PM - 01:00 PM Abstract 1-007 - Establishment of Normative Data for Quantitative Sudomotor Axon-Reflex Test from North India
Silky Adya
12:00 PM - 01:00 PM Abstract 1-008 - Cognitive performances in a cohort of Pure Autonomic Failure patients
Ilaria Cani, MD
12:00 PM - 01:00 PM Abstract 1-010 - Establishment of Normative Data for Thermoregulatory sweat test in Indian Population
Himani Khatter
12:00 PM - 01:00 PM Abstract 1-011 - Cutaneous Silent Periods in Patients with Early-Stage ALS
Joel Gutierrez, MD
12:00 PM - 01:00 PM Abstract 1-012 - A Retrospective Review of Radicava Experience Across US ALS Centers
John Furey
12:00 PM - 01:00 PM Abstract 1-013 - Predicting Survival in ALS Using Machine Learning Algorithms - a Preliminary Analysis
Bill Jacobsen, MD
12:00 PM - 01:00 PM Abstract 1-014 - Open-label Pilot Study of Ranolazine for Cramps in Amyotrophic Lateral Sclerosis (ALS).
Swathy Chandrashekhar, MD
12:00 PM - 01:00 PM Abstract 1-015 - The Comprehensive Analysis Platform To Understand, Remedy, and Eliminate ALS (CAPTURE ALS)
Sanjay Kalra, MD
12:00 PM - 01:00 PM Abstract 10-001 - The Relationship Between EEG Characteristics During Critical Illness and Long-Term Cognitive Impairment
Shawniqua Williams Roberson, MD
12:00 PM - 01:00 PM Abstract 10-002 - Comparison of EEG utilization patterns in Dementia with Lewy Bodies versus Alzheimer Disease
Jakob Mrozewski, MD
12:00 PM - 01:00 PM Abstract 10-003 - Genetic Architecture Drives Differences in RNA Editing Rates between Alzheimer Disease Cases and Controls in Diverse Populations
Olivia Gardner, MD, PhD
12:00 PM - 01:00 PM Abstract 10-004 - Meta-analysis of Gene Expression in Early-onset Alzheimer’s Disease
Daniela Lozano, MD
12:00 PM - 01:00 PM Abstract 10-005 - Melatonin Receptor-1B Genotype, KIBRA Genotype, and Possibly a-Klotho Plasma Level in Women are Associated with Incident Delirium in Elderly Post-surgical Patients
Mark Anthony Terrelonge, Jr., MD
12:00 PM - 01:00 PM Abstract 10-006 - Long-read Sequencing Identifies GGC Repeat Expansions in NOTCH2NLC as the Cause of Neuronal Intranuclear Inclusion Disease
Jun Sone, MD, PhD, FAAN
12:00 PM - 01:00 PM Abstract 10-007 - A novel T567M mutation outside the tyrosine kinase domain of CSF1R with clinical and radiological features of HDLS
Jonathan Yexian Lai, MBBS
12:00 PM - 01:00 PM Abstract 10-008 - Heat Shock Protein A12A Is Essential for Hippocampal Spinogenesis, Neurogenesis and Affective Behavior Development in Mice
Li Liu, MD
12:00 PM - 01:00 PM Abstract 10-009 - Using a Multimodal Biomarker Approach to Identify Functional Target Engagement of the Novel NMDA Positive Allosteric Modulator SAGE-718
Aaron Koenig
12:00 PM - 01:00 PM Abstract 10-011 - Role of NOX2 in the BDNF dysregulation and cognitive deficits after sepsis
Wan-Yu Huang
12:00 PM - 01:00 PM Abstract 4-001 - Anticoagulation with DOAC or Heparin Bridging in Acute Cardioembolic Stroke: Nationwide Retrospective Cohort Study Analysis in Japan
Takahisa Mikami, MD
12:00 PM - 01:00 PM Abstract 4-002 - Stroke Rates in Centrifugal Flow Left Ventricular Assist Devices: A Device-Specific Comparative Analysis
Catherine Hassett, MD
12:00 PM - 01:00 PM Abstract 4-003 - The “Natural History” of Stroke secondary to Atrial Fibrillation: two weeks without therapeutic anticoagulation.
Xiyan Yi, MD
12:00 PM - 01:00 PM Abstract 4-004 - Timing of Anticoagulation Post Atrial Fibrillation Related Ischemic Stroke
Alyson Rylie Plecash, MD
12:00 PM - 01:00 PM Abstract 4-005 - Ischemic and Hemorrhagic Strokes after Left Atrial Appendage Occlusion (LAAO): A Mayo Clinic Case Series
Chia-Chun Chiang, MD
12:00 PM - 01:00 PM Abstract 4-006 - Prevalence of Symptomatic and Asymptomatic Cerebrovascular Disease in Patients Undergoing Left Atrial Appendage Closure: A Three-Site 9-Year Review
Najiyah Salwa
12:00 PM - 01:00 PM Abstract 4-007 - The Fasting for Brain and Heart Health Study: Preliminary results
Eugene L. Scharf, MD
12:00 PM - 01:00 PM Abstract 4-008 - Measurement of Left Atrial Appendage Flow Velocity to Enhance Risk Assessment for Stroke in Atrial Fibrillation Patients
Eric Zhou, MD
12:00 PM - 01:00 PM Abstract 4-009 - Left Atrial Enlargement and Reduced Ejection Fraction are Independently Associated with Cardiomebolic Stroke
Maryam Hosseini, MD
12:00 PM - 01:00 PM Abstract 4-010 - The Growing Challenge of Post-TAVR Strokes
Kenneth Han
12:00 PM - 01:00 PM Abstract 4-012 - Recovered Neurological Worsening in Hospitalized Patients with Acute Ischemic Stroke
Jeong-Hoon Kim
12:00 PM - 01:00 PM Abstract 4-013 - In-Hospital Stroke: Risk Factors and Outcomes amongst Active Cancer Patients
Adriana Naomi Sari, MD
12:00 PM - 01:00 PM Abstract 4-014 - High Dose Aspirin Versus Clopidogrel After a Breakthrough Ischemic Event While on Low Dose Aspirin
Saurav Das, MD
12:00 PM - 01:00 PM Abstract 4-015 - The Relationship of Continous 24-Hour Admission Blood Pressure To Severity and Short-Term Outcome Amongst Stroke Patients At The University of Abuja Teaching Hospital, Abuja, Nigeria.
Ifeyinwa Ani-Osheku, MBBS
12:00 PM - 01:00 PM Abstract 4-016 - Relative Changes in Blood Pressure as a Predicative Measure of Ischemia in Inpatient Code Strokes
Jacob Didion, MD
12:00 PM - 01:00 PM Abstract 4-017 - PFO and Push-Ups: A Case Series of Valsalva Before Cryptogenic Stroke
Elle Wade, MD
12:00 PM - 01:00 PM Abstract 4-018 - Cangrelor as a bridging antiplatelet therapy in a patient with recent intracranial and cardiac stenting: A case report and review of literature
Subin Mathew, MD
12:00 PM - 01:00 PM Abstract 4-019 - Characterization of Unfractionated Heparin Infusions in a Comprehensive Stroke Center
Tess Fitzpatrick, MD
12:00 PM - 01:00 PM Abstract 4-020 - Simultaneous Hemorrhagic And Ischemic Strokes- A rare but vexing entity
Abdulrahman Bukhari, MBBS
12:00 PM - 01:00 PM Abstract 13-001 - The Effectiveness of Video Teaching of the Neurological Examination for Surgical and Neurosciences Nurses
Thomas James Williams, MD
12:00 PM - 01:00 PM Abstract 13-002 - The Impact of Early Introduction to Neurology for Underrepresented Minorities (URM) on Decision in Careers in Medicine
Aileen Cangiano-Heath, MD
12:00 PM - 01:00 PM Abstract 13-003 - A Novel Opportunity to Engage Underrepresented Youth in Neuroscience Education and Research
Nicte I. Mejia, MD, MPH, FAAN
12:00 PM - 01:00 PM Abstract 13-004 - Identifying Strategies in Patient Recruitment for Acute Stroke Clinical Trials
Mehnaaz Ali, MBBS
12:00 PM - 01:00 PM Abstract 13-005 - A Bibliometric Analysis of Publication Patterns of Neurology Articles in General Medicine Journals
Mitchell Wilson, MD
12:00 PM - 01:00 PM Abstract 13-006 - Qualitative Analysis of Neurology Consulting Services in a Pediatric Emergency Department
Matthew Hiller, MD
12:00 PM - 01:00 PM Abstract 13-007 - The Narrative Evaluation Quality Instrument: Development of a Tool to Assess the Assessor
Robert Ian Thompson-Stone, MD, FAAN
12:00 PM - 01:00 PM Abstract 13-008 - Why Neurology (or Not)? Understanding Career Decision-Making of First-Year Medical Students
Rachel J. Gottlieb-Smith, MD
12:00 PM - 01:00 PM Abstract 13-009 - A Stroke of Genius: Using Gaming to Reinforce Learning in Neurology Education
Ruchi Dhyani, MD
12:00 PM - 01:00 PM Abstract 13-010 - Neurology Problem Based Learning with Limited Neurologist Resources is Feasible
Irma Nora Duncan, MD
12:00 PM - 01:00 PM Abstract 13-011 - A Novel Goals of Care Communication Curriculum for Neurology Residents Improves Confidence and Skills
Tarini Goyal
12:00 PM - 01:00 PM Abstract 13-012 - Assessing Impact of Evidence-Based Pedagogic Techniques in Resident-Led Neurology Didactics
Adeolu Oluwaseun Morawo, MD
12:00 PM - 01:00 PM Abstract 13-013 - The Validity of the National In-training Examination for Canadian Pedatric Neurology Residents (NITECaP)
Sunita Venkateswaran, MD
12:00 PM - 01:00 PM Abstract 13-014 - Stroke Simulation during a Neurology Bootcamp
Alexandra Kvernland, MD
12:00 PM - 01:00 PM Abstract 5-001 - Risk of generalization in ocular myasthenia gravis after 10 years.
Antoine Gueguen, MD
12:00 PM - 01:00 PM Abstract 5-002 - Myasthenia Gravis in Monozygotic Twins
Robert Craig Coppola, DO
12:00 PM - 01:00 PM Abstract 5-003 - Predictive value of radiographic signs of raised intracranial pressure for the postoperative risk of recurrence of spontaneous cerebro-spinal fluid (CSF) leaks
Bryce Buchowicz, MD
12:00 PM - 01:00 PM Abstract 5-004 - Neuro-Imaging Evidence for Reversible Collapsibility of the Distal Transverse Sinuses in Spontaneous CSF Leak
Leanne Stunkel, MD
12:00 PM - 01:00 PM Abstract 5-005 - Abducens Nerve Palsy and Vision Loss Secondary to Erdheim-Chester Disease
Christina Yuen, MD
12:00 PM - 01:00 PM Abstract 5-006 - Sudden Severe Vision Loss And Persistent Vomiting: From A Suspicion Of Neuromyelitis Optica To A Diagnosis Of Acute Thinner Intoxication
Emerson de Paula Santos
12:00 PM - 01:00 PM Abstract 5-007 - Sildenafil Induced Headache and Blurry vision
Yin Allison Liu, MD
12:00 PM - 01:00 PM Abstract 5-008 - Determining the Best Functional and Structural Outcome to Measure the Deficits After an Episode of Optic Neuritis
Mark J. Kupersmith, MD, FAAN
12:00 PM - 01:00 PM Abstract 5-009 - Causes of Homonymous Macular Ganglion Cell Complex Atrophy on Optical Coherence Tomography without Significant Visual Field Changes
Mark Kenneth Lukewich
12:00 PM - 01:00 PM Abstract 5-010 - TITLE: Role for OCT in detecting homonymous ganglion cell layer thinning in patients with multiple sclerosis
Rachel Nolan
12:00 PM - 01:00 PM Abstract 5-011 - Identification of a novel mutation in Bosch-Boonstra-Schaaf Optic Atrophy Syndrome: Case Report and A Review of Literature
Sushant Puri, MBBS
12:00 PM - 01:00 PM Abstract 5-012 - Complex I Deficiency due to a Nuclear Mitochondrial DNA Mutation of the NDUFAF5 Gene Causing a Leber Hereditary Optic Neuropathy “Plus” Phenotypic Expression
Dev Mehta, DO
12:00 PM - 01:00 PM Abstract 5-013 - Atypical Presentation of Leber’s Hereditary Optic Neuropathy
Sara Rubenstein, MD
Faculty Disclosures
Douglas L. Arnold, MD, FAAN Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Celgene. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has stock in NeuroRx.
Richard J. Barohn, MD, FAAN Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Werner J. Becker, MD Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for McKesson. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for University of Calgary.
Suzanne N. Christie, MD No disclosure on file
Stanley L. Cohan, MD, PhD, FAAN Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb (Celgene). Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Icometrix. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for sanofi genzyme. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche Genentech. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Icometrix.
Jeffrey Alan Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gossamer Bio. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage.
Cynthia L. Comella, MD, FAAN Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda Therapeutics. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck LTD. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan Inc. Dr. Comella has received personal compensation in the range of $0-$499 for serving as a Consultant for Merz. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Dr. Comella has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Aeon. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz . Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care.
John W. Day, MD, PhD Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Affinia Therapeutics. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapy. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Muscular Dystrophy Association. The institution of Dr. Day has received research support from Audentes. The institution of Dr. Day has received research support from Novartis Gene Therapy. The institution of Dr. Day has received research support from Biogen. The institution of Dr. Day has received research support from Cytokinetics. The institution of Dr. Day has received research support from Roche/Genentech. The institution of Dr. Day has received research support from Sanofi/Genzyme. The institution of Dr. Day has received research support from Sarepta. The institution of Dr. Day has received research support from Scholar Rock. Dr. Day has received intellectual property interests from a discovery or technology relating to health care.
Darryl C. De Vivo, MD, FAAN Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen and Novartis. Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspa Therapeutics.
Peter J. Dyck, MD,FAAN Dr. Dyck has nothing to disclose.
Richard S. Finkel, MD, FAAN Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Capricor. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReveraGen. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Finkel has received research support from AveXis. The institution of Dr. Finkel has received research support from Biogen. The institution of Dr. Finkel has received research support from Capricor. The institution of Dr. Finkel has received research support from Catabasis. The institution of Dr. Finkel has received research support from ReveraGen. The institution of Dr. Finkel has received research support from Roche. The institution of Dr. Finkel has received research support from Scholar Rock. Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. Dr. Finkel has received personal compensation in the range of $0-$499 for serving as a Speaker in workshop with National Academy of Sciences. Dr. Finkel has a non-compensated relationship as a advisor with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Finkel has a non-compensated relationship as a Board Member with EveryLife Foundation that is relevant to AAN interests or activities.
John F. Foley, MD, FAAN The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Foley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Foley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Foley has stock in InterPRO Bioscience. The institution of Dr. Foley has received research support from Biogen. The institution of Dr. Foley has received research support from Novartis. The institution of Dr. Foley has received research support from Octave. The institution of Dr. Foley has received research support from Genentech. The institution of Dr. Foley has received research support from Imstem. The institution of Dr. Foley has received research support from Aegir.
Deborah I. Friedman, MD, MPH, FAAN Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Friedman has received personal compensation in the range of $0-$499 for serving as a Consultant for Satsuma. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Reviews. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology . The institution of Dr. Friedman has received research support from Spinal CSF Leak Foundation. Dr. Friedman has a non-compensated relationship as a Program Co-Chair, Scottsdale Headache Symposium with American Headache Society that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a Medical Advisor with Spinal CSF Leak Foundation that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a Treasurer, Board of Directors with Southern Headache Society that is relevant to AAN interests or activities.
Steven Galetta, MD, FAAN Dr. Galetta has nothing to disclose.
Douglas J. Gelb, MD, PhD, FAAN Dr. Gelb has received publishing royalties from a publication relating to health care. Dr. Gelb has received publishing royalties from a publication relating to health care. Dr. Gelb has received publishing royalties from a publication relating to health care. Dr. Gelb has received personal compensation in the range of $500-$4,999 for serving as a multiple choice question writer for Continuum with AAN.
James A. Goodwin, MD, FAAN No disclosure on file
Mark Forrest Gordon, MD, FAAN Dr. Gordon has received personal compensation for serving as an employee of Teva. Dr. Gordon has stock in Teva.
John E. Greenlee, MD, FAAN Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Zeigler Cohen Roche. Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sommers Schwartz PC. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for St Francis Hospital. Dr. Greenlee has received publishing royalties from a publication relating to health care. Dr. Greenlee has received publishing royalties from a publication relating to health care.
Robert A. Hauser, MD, MBA, FAAN Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Global Kinetics Consulting (GKC). Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroDerm. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion Neurostim LLC. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tolmar Inc.. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus Pharma. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inhibikase. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pharma 2 B. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivifi Biotech. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ovid Therapeutics. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AgeX Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanex. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MDCE Suzhou. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedRhythms. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PDNeurotechnology. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Regenxbio. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Tremor Research Support Group. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tris Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda Therapeutics. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Ameal . Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sunovion. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Cerevel. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Inhibikase. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has stock in Inhibikase. Dr. Hauser has stock in Axial Therapeutics. Dr. Hauser has stock in Enterin. Dr. Hauser has stock in Revance Therapeutics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Artizan Biosciences. The institution of Dr. Hauser has received research support from Parkinsons & Movement Disorder Alliance. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Aeon Biopharma. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Bukwang Pharmaceutical Co., Ltd.. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Cynapsus Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Impax Labratories. The institution of Dr. Hauser has received research support from Integrative Research Labratories Sweden. The institution of Dr. Hauser has received research support from Lundbeck, Inc.. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuraly Inc.. The institution of Dr. Hauser has received research support from Neurocrine Biosciences. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Pharma Two B Ltd.. The institution of Dr. Hauser has received research support from Revance Therapeutics. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Sanofi Pharmaceuticals. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from SunPharma. The institution of Dr. Hauser has received research support from UCB BioPharma. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Stephen L. Hauser, MD Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Susan T. Iannaccone, MD, FAAN Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AveXis. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. The institution of Dr. Iannaccone has received research support from AveXis. The institution of Dr. Iannaccone has received research support from Biogen. The institution of Dr. Iannaccone has received research support from Sarepta. The institution of Dr. Iannaccone has received research support from PTC Therapeutics. The institution of Dr. Iannaccone has received research support from FibroGen. The institution of Dr. Iannaccone has received research support from ReveraGen. The institution of Dr. Iannaccone has received research support from MDA. The institution of Dr. Iannaccone has received research support from PPMD. The institution of Dr. Iannaccone has received research support from NIH. Dr. Iannaccone has received personal compensation in the range of $0-$499 for serving as a grant reviewer with NIH.
Safwan S. Jaradeh, MD, FAAN Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam & Akcea. The institution of Dr. Jaradeh has received research support from Alnylam.
Horacio C. Kaufmann, MD, FAAN Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly USA. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharma UK Ltd. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaxxinity. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. Dr. Kaufmann has received publishing royalties from a publication relating to health care.
Bhupendra O. Khatri, MD, FAAN Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for ER Squibb (Bristol Myer Squibb). Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizone. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyne. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seronoe. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for E.R. Squibb. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutic. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx US. The institution of Dr. Khatri has received research support from Biogen.
Lauren B. Krupp, MD, FAAN Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lerhman. Dr. Krupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for medscape. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLive. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Krupp has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Cleveland Clinic. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for MCIC. The institution of Dr. Krupp has received research support from Biogen. The institution of Dr. Krupp has received research support from National Multiple Sclerosis Society. Dr. Krupp has received intellectual property interests from a discovery or technology relating to health care.
Nancy L. Kuntz, MD, FAAN Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Affinia Therapeutics. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Audentes Therapeutics. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kuntz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta.
Mark J. Kupersmith, MD, FAAN Dr. Kupersmith has nothing to disclose.
Morris Levin, MD, FAAN Dr. Levin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus, Upsher Smith, Biohaven, Revance, Percept, Theranica, Allergan, Alder, Currax. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Attorney . Dr. Levin has received stock or an ownership interest from Percept. Dr. Levin has received publishing royalties from a publication relating to health care.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Phillip A. Low, MD, FAAN Dr. Low has nothing to disclose.
Sharon G. Lynch, MD, FAAN The institution of Dr. Lynch has received research support from National MS society. The institution of Dr. Lynch has received research support from PCORI. The institution of Dr. Lynch has received research support from Novartis. The institution of Dr. Lynch has received research support from Roche. The institution of Dr. Lynch has received research support from Chugai. The institution of Dr. Lynch has received research support from Sanofi. The institution of Dr. Lynch has received research support from Alexion. The institution of Dr. Lynch has received research support from EMD Serono. The institution of Dr. Lynch has received research support from Celgene. The institution of Dr. Lynch has received research support from Atara. The institution of Dr. Lynch has received research support from TG Therapeutics. The institution of Dr. Lynch has received research support from Medimmune. The institution of Dr. Lynch has received research support from Anokion. The institution of Dr. Lynch has received research support from Adamas. Dr. Lynch has a non-compensated relationship as a Board Memeber of the mid-America Chapter with National MS Society that is relevant to AAN interests or activities. Dr. Lynch has a non-compensated relationship as a President of Board of Directors with Friends of MS Achievement Center that is relevant to AAN interests or activities.
Laszlo Mechtler, MD, FAAN, FASN Dr. Mechtler has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Jushi Inc. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Mechtler has received stock or an ownership interest from Jushi Co.. The institution of Dr. Mechtler has received research support from The Harry Dent Family Foundation, Inc. The institution of Dr. Mechtler has received research support from Amgen/Novartis. The institution of Dr. Mechtler has received research support from Alder/ Lundbeck. The institution of Dr. Mechtler has received research support from Abbvie/Allergan. The institution of Dr. Mechtler has received research support from Miles for Migraine. The institution of Dr. Mechtler has received research support from American Migraine Foundation. The institution of Dr. Mechtler has received research support from Charlotte's Web.
Martha A. Nance, MD Dr. Nance has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Voyager. Dr. Nance has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROche. Dr. Nance has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Nance has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. An immediate family member of Dr. Nance has received stock or an ownership interest from Fresca. The institution of Dr. Nance has received research support from HDSA. The institution of Dr. Nance has received research support from Parkinson Foundation. Dr. Nance has received research support from Parkinson Foundation. The institution of Dr. Nance has received research support from Neuraly. Dr. Nance has received personal compensation in the range of $500-$4,999 for serving as a speaker with AAN.
Nancy J. Newman, MD, FAAN Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurophoenix. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurophth. The institution of Dr. Newman has received research support from GenSight. The institution of Dr. Newman has received research support from Chiesi/Santhera. The institution of Dr. Newman has received research support from NINDS/NIH. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care.
J. Theodore Phillips, MD, PhD, FAAN No disclosure on file
Alan M. Rapoport, MD, FAAN Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie, Amgen, Biohaven, Cala Health, Satsuma, Teva Pharmaceutical Industries, Theranica, Xoc and Zosano. Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Amgen, Biohaven, Lundbeck and Teva Pharmaceutical Industries. Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Reviews.
John W. Rose, MD, FAAN The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Carlos Singer, MD Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Video Panel with CNS Ratings LLC. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Course Organiztion with Omniprex Scientific Medical Eduaction. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with Health Monitor Network. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Movement Disorders Society. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Workshop Moderator with International Neurotoxin Association Inc. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Lecturer with CME Outfitteres LLC.
Stewart J. Tepper, MD Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Becker Pharmaceutical Consulting. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cleaview Healhcare Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CRG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Decision Resources. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Defined Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DRG. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fenix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Science Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Communications. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InteractiveForums. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keyquest. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Krog and Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magnolia Innovation. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Holdings. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for P Value Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pain Insights Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Palion Medical. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulmatrix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAI MedPartners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strategy Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for System Medical Comm. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taylor and Francis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UnityHA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XOC. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miravo. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurofront Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehaler. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scilex. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communication. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tegus. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ClickTherapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miravo Healthcare. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pulmatrix. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Pfizer. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Scilex. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Diamond Headache Clinic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Education Speakers Network. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Miller Medical Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Physicians' Education Resource. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with WebMD/Medscape. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with American Headache Society. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Vindico Medical Education. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with HMP Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CMe speaker with Medical Learning Institute Peerview.
Joel M. Trugman, MD, FAAN Dr. Trugman has received personal compensation for serving as an employee of AbbVie. Dr. Trugman has stock in AbbVie.
Jeffery M. Vance, MD, PhD Dr. Vance has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for neurology genetics.
Jerry S. Wolinsky, MD, FAAN Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Orla Hardiman, MD, FRCP, FAAN Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Lawrence C. Newman, MD, FAAN Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan . Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Newman has received publishing royalties from a publication relating to health care.
Thomas F. Scott, MD Dr. Scott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Scott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serono. Dr. Scott has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme. Dr. Scott has received research support from Biogen. Dr. Scott has received research support from Novartis.
Ludwig Kappos, MD, FAAN The institution of Dr. Kappos has received research support from Bayer. The institution of Dr. Kappos has received research support from Biogen. The institution of Dr. Kappos has received research support from Genentech. The institution of Dr. Kappos has received research support from Genzyme. The institution of Dr. Kappos has received research support from Janssen. The institution of Dr. Kappos has received research support from Merck Serono. The institution of Dr. Kappos has received research support from Minoryx. The institution of Dr. Kappos has received research support from Novartis. The institution of Dr. Kappos has received research support from Roche. The institution of Dr. Kappos has received research support from Sanofi. The institution of Dr. Kappos has received research support from Santhera. The institution of Dr. Kappos has received research support from Swiss MS Society, Swiss National Research Foundation, European Union, Roche Research Foundation, Innosuisse. The institution of Dr. Kappos has received research support from Shionogi. The institution of Dr. Kappos has received research support from Japan Tobacco. The institution of Dr. Kappos has received research support from Auriga Vision AG. The institution of Dr. Kappos has received research support from EMD Serono. The institution of Dr. Kappos has received research support from Glaxo Smith Kline. The institution of Dr. Kappos has received research support from Wellmera AG. The institution of Dr. Kappos has received research support from Eli Lilly (Suisse) SA. The institution of Dr. Kappos has received research support from Bristol Myers Squibb. The institution of Dr. Kappos has received research support from Celltrion Inc. Dr. Kappos has received intellectual property interests from a discovery or technology relating to health care.
Paul Matthews, MD No disclosure on file
Angela L. Genge, MD Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE.
Mercedes P. Jacobson, MD The institution of Dr. Jacobson has received research support from Engage. The institution of Dr. Jacobson has received research support from XENON. The institution of Dr. Jacobson has received research support from SK Life Sciences.
Margaret A. Pericak-Vance, PhD Dr. Pericak-Vance has nothing to disclose.
Becky J. Parks, MD Dr. Parks has received personal compensation for serving as an employee of Alexion Pharmaceuticals. An immediate family member of Dr. Parks has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Parks has stock in Biogen. Dr. Parks has stock in Illumina. An immediate family member of Dr. Parks has stock in Regeneron. Dr. Parks has stock in Blueprint Medicines. Dr. Parks has stock in Sanofi. An immediate family member of Dr. Parks has stock in Vertex. Dr. Parks has stock in AstraZeneca. The institution of an immediate family member of Dr. Parks has received research support from NIH/NCI. The institution of an immediate family member of Dr. Parks has received research support from Leukemia & Lymphoma Society. The institution of an immediate family member of Dr. Parks has received research support from AstraZeneca Scholar Award.
Richard A L Macdonell, MD, FAAN Dr. Macdonell has nothing to disclose.
Pietro Cortelli, MD, FAAN Dr. Cortelli has nothing to disclose.
Mustapha A. Danesi, MD No disclosure on file
Mazen M. Dimachkie, MD, FAAN Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EcoR1 Capital, LLC. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cello Health BioConsulting, previously Defined Health. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for RAF-5. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Houston NeuroCare. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shire. Dr. Dimachkie has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kezar. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for RaPharma/UCB. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. An immediate family member of Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kezar. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SCHOLAR Rock. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jenssen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amazentis / Vandria. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roivant. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SANEM. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Rock. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphazyme . Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roivant . Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Covance / Labcorp. The institution of Dr. Dimachkie has received research support from CSL Behring. The institution of Dr. Dimachkie has received research support from Orphazyme. The institution of Dr. Dimachkie has received research support from FDA-OOPD. The institution of Dr. Dimachkie has received research support from NIH. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Seemant Chaturvedi, MD, FAAN, FAHA Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Calgary. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Ramar & Paradiso. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Cole, Scott, Kissane. The institution of Dr. Chaturvedi has received research support from NINDS.
Takashi Inuzuka, MD, FAAN No disclosure on file
Oscar R. Benavente, MD, FRCP(C) No disclosure on file
Basil T. Darras, MD The institution of Dr. Darras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Darras has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. The institution of Dr. Darras has received research support from National Institutes of Health/National Institute of Neurological Disorders and Stroke,. The institution of Dr. Darras has received research support from Slaney Family Fund for SMA. The institution of Dr. Darras has received research support from Spinal Muscular Atrophy Foundation. The institution of Dr. Darras has received research support from CureSMA. The institution of Dr. Darras has received research support from Working on Walking Fund . The institution of Dr. Darras has received research support from CHERISH, CS2/CS12 . The institution of Dr. Darras has received research support from Biogen for CS11. The institution of Dr. Darras has received research support from AveXis. The institution of Dr. Darras has received research support from Sarepta Pharmaceuticals. The institution of Dr. Darras has received research support from PTC Therapeutics. The institution of Dr. Darras has received research support from Roche. The institution of Dr. Darras has received research support from Santhera. The institution of Dr. Darras has received research support from Scholar Rock. The institution of Dr. Darras has received research support from Fibrogen. The institution of Dr. Darras has received research support from Summit. Dr. Darras has received publishing royalties from a publication relating to health care. Dr. Darras has received publishing royalties from a publication relating to health care.
Kathryn J. Swoboda, MD Dr. Swoboda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Swoboda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Swoboda has received research support from Biogen.
David W. Dodick, MD, FAAN Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Education Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with American Academy of Neurology that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Robert Croop, MD Dr. Croop has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Dr. Croop has received personal compensation for serving as an employee of Pfizer Inc.. Dr. Croop has stock in Biohaven Pharmaceutical Holding Co Ltd. Dr. Croop has stock in Biohaven Ltd.. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care.
Karen L. Furie, MD The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ACTICOR. Dr. Furie has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Laura J. Balcer, MD, MSCE, FAAN An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia. Dr. Balcer has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for North American Neuro-Ophthalmology Society.
Sanjay Gandhi, MD Dr. Gandhi has received personal compensation for serving as an employee of Teva Pharmaceuticals.
David M. Greer, MD, FAAN Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. The institution of Dr. Greer has received research support from Becton, Dickinson and Company. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care.
P. James B. Dyck, MD, FAAN Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Isao Hozumi, MD, PhD No disclosure on file
Valerie Biousse, MD Dr. Biousse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gensights Biologic. Dr. Biousse has received personal compensation in the range of $0-$499 for serving as a Consultant for Neurophoenix. The institution of Dr. Biousse has received research support from NIH. Dr. Biousse has received publishing royalties from a publication relating to health care. Dr. Biousse has received publishing royalties from a publication relating to health care.
James F. Meschia, MD, FAAN The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.
Blair Leavitt, MD Dr. Leavitt has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Incisive Genetics. Dr. Leavitt has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Leavitt has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Design TX. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReMix Tx. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sintetica. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Triplet Tx. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Leavitt has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Incisive Genetics. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Huntington's Disease. Dr. Leavitt has stock in Incisive Genetics. Dr. Leavitt has stock in SRNAlytics. The institution of Dr. Leavitt has received research support from CIHR. The institution of Dr. Leavitt has received research support from HSC. The institution of Dr. Leavitt has received research support from Brain Canada. The institution of Dr. Leavitt has received research support from NMIN. Dr. Leavitt has received intellectual property interests from a discovery or technology relating to health care.
Nicholas D. Schiff, MD Dr. Schiff has received publishing royalties from a publication relating to health care. Dr. Schiff has received personal compensation in the range of $500-$4,999 for serving as a study section member with NIH. Dr. Schiff has a non-compensated relationship as a Guidelines Panel Member with AAN that is relevant to AAN interests or activities.
Ralf Gold, MD Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Gyula Acsadi, MD, FAAN Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avexis. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serepta. Dr. Acsadi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Xue Ming, MD Dr. Ming has nothing to disclose.
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen/Actelion. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atara Biotherapeutics. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech. The institution of Dr. Bar-Or has received research support from Merck/EMD Serono.
Sanjeev V. Kothare, MD, FAAN Dr. Kothare has nothing to disclose.
Hidehiro Mizusawa, MD, PhD No disclosure on file
Konstantin E. Balashov, MD, PhD, FAAN Dr. Balashov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Amir Manzoor Arain, MD, FAAN Dr. Arain has nothing to disclose.
Sanjay Kalra, MD The institution of Dr. Kalra has received research support from Brain Canada Foundation. The institution of Dr. Kalra has received research support from Biogen.
Michael J. Polydefkis, MD, FAAN Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceutical . Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer.
Jonathan Haines, MD No disclosure on file
Olivier F. Gout, MD Dr. Gout has nothing to disclose.
Gavin Giovannoni, MD Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Japanese Tobacco. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aurinia Pharmaceuticals. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Oxford Health Policy Forum. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Peervoice. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Bristows .
Maria Trojano Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi_Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Robert J. Fox, MD, FAAN Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for INmune Bio. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lily. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Biosciences. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
James K. Sheffield, MD Dr. Sheffield has received personal compensation for serving as an employee of BMS.
William Scott Burgin, MD Dr. Burgin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for VuEssence. Dr. Burgin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Burgin has stock in VuEssence. The institution of Dr. Burgin has received research support from VuEssence. The institution of Dr. Burgin has received research support from Bristol-Myers Squibb. The institution of Dr. Burgin has received research support from ReNeuron.
Ken Uchino, MD Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aboott Laboratories, Inc.. Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACP JOURNAL CLUB. The institution of Dr. Uchino has received research support from NIH.
Masashi Aoki, MD,PhD No disclosure on file
Richard Hargreaves, PhD No disclosure on file
Kazutoshi Nishiyama, MD, PhD Kazutoshi Nishiyama, MD, PhD has nothing to disclose.
Helmut Butzkueven, MD, MBBS Dr. Butzkueven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oxford Health Policy Forum. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase . The institution of Dr. Butzkueven has received research support from NHMRC. The institution of Dr. Butzkueven has received research support from Biogen. The institution of Dr. Butzkueven has received research support from Roche. The institution of Dr. Butzkueven has received research support from Novartis.
Jonathan J. Halford, MD Dr. Halford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life Sciences. Dr. Halford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Halford has received stock or an ownership interest from Corticare. The institution of Dr. Halford has received research support from Takeda. The institution of Dr. Halford has received research support from SK Life Sciences. The institution of Dr. Halford has received research support from Biogen.
Nicolas Dupre, MD, FAAN Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Eric J. Eross, DO No disclosure on file
Gen Sobue, MD Dr. Sobue has nothing to disclose.
Hiroshi Takashima, MD, PhD Dr. Takashima has nothing to disclose.
Takayoshi Shimohata, MD, FAAN Dr. Shimohata has nothing to disclose.
Kevin M. Barrett, MD, FAAN Dr. Barrett has nothing to disclose.
Ralph H. B. Benedict, PhD Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Benedict has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Benedict has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Brystal Mier Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Benedict has received research support from Genzyme. The institution of Dr. Benedict has received research support from Biogen. The institution of Dr. Benedict has received research support from Bristol Myer Squib. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Maria K. Houtchens, MD Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serono. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cravath. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Beasley . Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Biogen. The institution of Dr. Houtchens has received research support from Genzyme. The institution of Dr. Houtchens has received research support from Biogen. The institution of Dr. Houtchens has received research support from Genentech.
Khalid I. El-Salem, MD, FAAN Dr. El-Salem has nothing to disclose.
Deborah L. Renaud, MD No disclosure on file
Michael Dobbs, MD Dr. Dobbs has received publishing royalties from a publication relating to health care.
Bruce A. C. Cree, MD, PhD, MCR, FAAN The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avotres. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. Dr. Cree has received publishing royalties from a publication relating to health care.
Jayne Ness, MD An immediate family member of Dr. Ness has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jan One. The institution of Dr. Ness has received research support from Chugai/Roche. The institution of Dr. Ness has received research support from National Multiple Sclerosis Society. The institution of an immediate family member of Dr. Ness has received research support from NIH. An immediate family member of Dr. Ness has received publishing royalties from a publication relating to health care.
David Callen, MD No disclosure on file
Takashi Kanda, MD No disclosure on file
Makiko Nagai, MD No disclosure on file
Basil Sharrack, MD, PhD, FAAN Dr. Sharrack has nothing to disclose.
Wolfgang Singer, MD Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. The institution of Dr. Singer has received research support from NIH. The institution of Dr. Singer has received research support from FDA. The institution of Dr. Singer has received research support from Michael J. Fox Foundation. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care.
Eva Havrdova, MD Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Joel Gutierrez, MD No disclosure on file
Amit Shankar Singh, MD Dr. Singh has nothing to disclose.
M. Tariq Bhatti, MD Dr. Bhatti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Receptos . Dr. Bhatti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH LHON gene therapy study .
Shyam Prabhakaran, MD The institution of Dr. Prabhakaran has received research support from NIH . The institution of Dr. Prabhakaran has received research support from AHRQ. Dr. Prabhakaran has received publishing royalties from a publication relating to health care.
Cara E. Harth, MD, FAAN Dr. Harth has received personal compensation in the range of $500-$4,999 for serving as a In-House Expert Reviewer with Academic Group.
Gary Raymond Cutter, PhD Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biodelivery Sciences International, Biogen, Click Therapeutics, Genzyme, Genentech, GW Pharmaceuticals, Immunic, Klein-Buendel Incorporated, Medimmune/Viela Bio, Medday, Merck/Serono, Neurogenesis LTD, Novartis, Osmotica Pharmaceuticals, Perception Neurosciences, Recursion/Cerexis Pharmaceuticals, Regeneron, Reckover Pharmaceuticals, Roche, TG Therapeutics.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics, AI therapeutics, AMO Pharma, Astra-Zeneca, Avexis Pharmaceuticals, Biolinerx, Brainstorm Cell Therapeutics, Bristol Meyers Squibb/Celgene, CSL Behring, Galmed Pharmaceuticals, Green Valley Pharma, Horizon Pharmaceuticals, Immunic, Karuna Therapeutics, Mapi Pharmaceuticals LTD, Merck, Mitsubishi Tanabe Pharma Holdings, Opko Biologics,Prothena Biosciences, Novartis, Regeneron, Sanofi-Aventis, Reata Pharmaceuticals, NHLBI (Protocol Review Committee), University of Texas Southwestern, University of Pennsylvania, Visioneering Technologies, Inc.. Dr. Cutter has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Heinz Wiendl, MD, FAAN Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NexGen. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Worldwide Clinical Trials. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gossamer Bio. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Toleranzia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Robert A. Bermel, MD Dr. Bermel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bio. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck Serono. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca. Dr. Bermel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Adrian Ares-Luque, MD Dr. Ares-Luque has nothing to disclose.
Federica Provini No disclosure on file
Michael Phipps, MD, MHS, FAAN Dr. Phipps has nothing to disclose.
Yang Mao-Draayer, MD Dr. Mao-Draayer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen Idec. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Mao-Draayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizone . Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizone. Dr. Mao-Draayer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Mao-Draayer has received research support from NIH . The institution of Dr. Mao-Draayer has received research support from Genzyme-Sanofi. The institution of Dr. Mao-Draayer has received research support from Novartis. The institution of Dr. Mao-Draayer has received research support from Genentech.
Stephan Schuele, MD, FAAN Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Schuele has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz. Dr. Schuele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Thomas Needham. Dr. Schuele has received research support from National Institute of Health.
Ann Helms, MD Dr. Helms has nothing to disclose.
Shafeeq Ladha, MD Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Ladha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurosense. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapa Therapeutics. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ladha has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. The institution of Dr. Ladha has received research support from Biogen. The institution of Dr. Ladha has received research support from Sanofi.
Asif Doja, MD, FAAN Dr. Doja has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for the CMPA. Dr. Doja has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Integra . Dr. Doja has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Connect Care .
Laura Herbelin No disclosure on file
Dmitry Khaitov, MD Dr. Khaitov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Ilya Kister, MD, FAAN Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Nirmal Surya, MD, DNB, FAAN Dr. Surya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB india, Abbot and Esai pharma. Dr. Surya has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbot. Dr. Surya has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ESAI pharma. Dr. Surya has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Movement disorder society.
Morris Maizels No disclosure on file
Jeyaraj Durai Pandian, MD, DM Dr. Pandian has nothing to disclose.
Tjalf Ziemssen, MD, FAAN Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS Celgene. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS Celgene. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Ziemssen has received research support from Biogen. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from Celgene.
Ebrima Gibbs, Bsc,BMLSc,MSc Dr. Gibbs has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Promis Neuroscinces.
Fabrizio Giuliani, MD No disclosure on file
Claudia A. Chiriboga, MD, FAAN Dr. Chiriboga has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentec. Dr. Chiriboga has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Chiriboga has received research support from Roche. The institution of Dr. Chiriboga has received research support from Avexis/Novartis. The institution of Dr. Chiriboga has received research support from Biogen. The institution of Dr. Chiriboga has received research support from NIH. The institution of Dr. Chiriboga has received research support from Biohaven. The institution of Dr. Chiriboga has received research support from Genentec. Dr. Chiriboga has received publishing royalties from a publication relating to health care.
E. Ray Dorsey, MD, MBA Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BrainNeuroBio. Dr. Dorsey has received personal compensation in the range of $0-$499 for serving as a Consultant for Clintrex. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen Therapeutics. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali Therapeutics. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Dorsey has received personal compensation in the range of $0-$499 for serving as a Consultant for Grand Rounds. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medopad. Dr. Dorsey has received personal compensation in the range of $0-$499 for serving as a Consultant for Michael J. Fox Foundation. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Origent Data Sciences, Inc.. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Otsuka. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Spark. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion Pharma. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theravance. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Voyager Therapeutics. Dr. Dorsey has received personal compensation in the range of $0-$499 for serving as a Consultant for Alzheimer's Drug Discovery Foundation. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial-Biotech Investments, Inc.. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BluePrint Orphan, Inc.. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Caraway T. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DeciBio. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mediflix. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NACCME/CONSULTANT 360. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Dorsey has received personal compensation in the range of $0-$499 for serving as a Consultant for Olson Research Group. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pear Therapeutics. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spark. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Caraway. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Huntington Study Group. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Voyager. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech/Roche. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ANA. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MCM Education. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Physician's Education Resource, LLC. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Texas Neurological Society. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Karger. Dr. Dorsey has stock in Grand Rounds. The institution of Dr. Dorsey has received research support from Biogen - WATCH-PD. The institution of Dr. Dorsey has received research support from NIH - AHPD. Dr. Dorsey has received research support from NIH - Biosensics. The institution of Dr. Dorsey has received research support from Pfizer - SQUAD. The institution of Dr. Dorsey has received research support from Greater Rochester Health Foundation - PDCNY. The institution of Dr. Dorsey has received research support from Safra Foundation - PDCNY. The institution of Dr. Dorsey has received research support from Burroughs Wellcome - Smartphones. The institution of Dr. Dorsey has received research support from NIH - CTSA. The institution of Dr. Dorsey has received research support from Gary & Mary West Foundation - d.health. The institution of Dr. Dorsey has received research support from PCORI -PD Virtual Care. The institution of Dr. Dorsey has received research support from WAVE Life Sciences. The institution of Dr. Dorsey has received research support from Acadia Pharmaceuticals - PDTV. The institution of Dr. Dorsey has received research support from Roche Pharmaceuticals - PDTV. The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Fox Insight. The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Emerald. The institution of Dr. Dorsey has received research support from PCORI. The institution of Dr. Dorsey has received research support from Safra Foundation.
Catherine Vignal-Clermont, MD Dr. Vignal-Clermont has nothing to disclose.
Mamatha Pasnoor, MD, FAAN Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda Pharmaceuticals. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for catalyst pharmaceuticals. Dr. Pasnoor has received research support from NIH.
Stacey Clardy, MD, PhD, FAAN Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from Sumaira Foundation for NMO. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with Barrow Neurological Institute. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with Beaumont Health. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with Stanford. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with Cleveland Clinic.
Dena Dubal, MD, PhD No disclosure on file
Noel Carlson, PhD The institution of Mr. Carlson has received research support from Biogen. Mr. Carlson has received personal compensation in the range of $100,000-$499,999 for serving as a Employee as a Researcher with Veteran Affairs.
Andrew M. Blumenfeld, MD, FAAN Dr. Blumenfeld has received personal compensation for serving as an employee of The Los Angeles Headache Center. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctors. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GLG. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revance. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Blumenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck.
Jeenendra Prakash Singhvi, MD, FAAN Dr. Singhvi has nothing to disclose.
Nicte I. Mejia, MD, MPH, FAAN Dr. Mejia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Mejia has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Mejia has received research support from Biogen Foundation.
Scott Douglas Newsome, DO, FAAN Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from The Stiff Person Syndrome Research Foundation. The institution of Dr. Newsome has received research support from Lundbeck. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Carolina Ionete, MD Dr. Ionete has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Ionete has received research support from Genetech. The institution of Dr. Ionete has received research support from Biogen. The institution of Dr. Ionete has received research support from NIH.
Erin Furr-Stimming, MD, FAAN Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Michael J. Fox Foundation. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. The institution of Dr. Furr-Stimming has received research support from Huntington's Disease Society of America. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. The institution of Dr. Furr-Stimming has received research support from Sage Therapeutics. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care.
Joshua M. Cohen, MD No disclosure on file
Mirela Cerghet, MD, PhD, FAAN Dr. Cerghet has nothing to disclose.
Pragnesh P. Parikh No disclosure on file
Patrick Vermersch Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Leah Jin No disclosure on file
Samuel Yip, MD, PhD Dr. Yip has nothing to disclose.
Max R. Lowden, MD, FAAN Dr. Lowden has nothing to disclose.
Aileen Cangiano-Heath, MD Dr. Cangiano-Heath has nothing to disclose.
Krupa Shah Pandey, MD Dr. Pandey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Pandey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pandey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Pandey has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Pandey has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen . Dr. Pandey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech . Dr. Pandey has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Horizon Therapeutics . The institution of Dr. Pandey has received research support from NIH. The institution of Dr. Pandey has received research support from CMSC.
Hussam A. Yacoub, DO Dr. Yacoub has nothing to disclose.
Kerry Louise Knievel, DO Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amgen . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven . An immediate family member of Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck . Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith . Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica . Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven . Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific . Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Pfizer. Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sanders and Parks. The institution of Dr. Knievel has received research support from Abbvie . The institution of Dr. Knievel has received research support from Alder.
Tai Hwan Park, MD No disclosure on file
Simon Hawke No disclosure on file
Antoine Gueguen, MD No disclosure on file
Anna Marisa Cervantes-Arslanian, MD, FAAN Dr. Cervantes-Arslanian has nothing to disclose.
Susan Hutchinson Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alder Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allergan Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Currax Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for electroCore. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $0-$499 for serving as a Consultant for Lundbeck Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/AbbVie. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven . Susan Hutchinson has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific . Susan Hutchinson has received publishing royalties from a publication relating to health care.
Romain Deschamps Romain Deschamps has nothing to disclose.
Kerstin Hellwig Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for INC research . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from TEVA.
Samhita Panda, MD, DM Dr. Panda has nothing to disclose.
Vanja C. Douglas, MD Dr. Douglas has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various legal firms. Dr. Douglas has received publishing royalties from a publication relating to health care. Dr. Douglas has received publishing royalties from a publication relating to health care.
Jessica Ailani, MD, FAAN Dr. Ailani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allergan/Abbvie. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GlaxoSmithKline. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gore. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr. Reddy. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eneura. Dr. Ailani has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Report. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medscape. The institution of Dr. Ailani has received research support from Satsuma. The institution of Dr. Ailani has received research support from Ipsen. The institution of Dr. Ailani has received research support from Parema. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Medical Advisor with SELF.
Sunita Venkateswaran, MD Dr. Venkateswaran has nothing to disclose.
Shefali Karkare, MD Dr. Karkare has nothing to disclose.
on Behalf of the CLASSIC-MS Steering Committee No disclosure on file
James C. Jackson No disclosure on file
Raya Abughanmi No disclosure on file
Lianna S. Ishihara, MPhil No disclosure on file
Peter B. Forgacs, MD Dr. Forgacs has received personal compensation for serving as an employee of OVID Therapeutics Inc. Dr. Forgacs has received stock or an ownership interest from OVID Therapeutics Inc.
Erdem Tuzun Erdem Tuzun has nothing to disclose.
Hiroyuki Ishiura, MD No disclosure on file
Njide Okubadejo, MD, FAAN No disclosure on file
Jacqueline Montes, PT, EdD, NCS Ms. Montes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffman LaRoche. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Ms. Montes has received research support from NIH/NICHD. The institution of Ms. Montes has received research support from Muscular Dystrophy Association. The institution of Ms. Montes has received research support from Cure SMA.
Sarah J. Tabrizi, MD, PhD Sarah J. Tabrizi, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for F. Hoffmann-La Roche Ltd. Sarah J. Tabrizi, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Chris Chengke Tang, MD No disclosure on file
Luisa Hildegard Klotz, MD Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Klotz has received research support from Immunic AG. The institution of Dr. Klotz has received research support from Merck.
Heather Moss, MD, PhD, FAAN Dr. Moss has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Twenty Twenty Therapeutics. Dr. Moss has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Verana Health. Dr. Moss has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Inc. Dr. Moss has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms. The institution of Dr. Moss has received research support from NIH. The institution of Dr. Moss has received research support from Department of Defense. The institution of Dr. Moss has received research support from Research to Prevent Blindness. Dr. Moss has received intellectual property interests from a discovery or technology relating to health care. Dr. Moss has received personal compensation in the range of $0-$499 for serving as a grant review panel with NASA. Dr. Moss has received personal compensation in the range of $0-$499 for serving as a grant review panel with National Institutes of Health. Dr. Moss has a non-compensated relationship as a Board of Directors with North American Neuro-ophthalmology Society that is relevant to AAN interests or activities.
Vishal Patel, MD No disclosure on file
Harald Murck No disclosure on file
Hitoshi Aizawa No disclosure on file
Tariq M. Aziz No disclosure on file
Jeffrey Statland, MD Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
Dawn C. Buse, PhD Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Collegium. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Chongshu Chen Chongshu Chen has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Chongshu Chen has stock in Alnylam Pharmaceuticals.
Mohammad Shafie, MD Dr. Shafie has nothing to disclose.
Robert Ian Thompson-Stone, MD, FAAN Dr. Thompson-Stone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Conway Homer PC.
Angela Dispenzieri No disclosure on file
Lana Zhovtis Ryerson, MD Dr. Zhovtis Ryerson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Zhovtis Ryerson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Zhovtis Ryerson has received research support from Biogen. The institution of Dr. Zhovtis Ryerson has received research support from Genentech.
Astrid Gendolla No disclosure on file
Yi Luo No disclosure on file
Lucy *use 348863 Norcliffe-Kaufmann No disclosure on file
Sian Price No disclosure on file
Tatsushi Toda No disclosure on file
Makoto Urushitani No disclosure on file
Lily Wang No disclosure on file
Yue Wang No disclosure on file
David Z. Rose, MD Dr. Rose has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Boston Scientific. Dr. Rose has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Chiesi USA. Dr. Rose has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medtronic. Dr. Rose has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Boehringer Ingelheim . Dr. Rose has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL-Behring .
Shibeshih Belachew, MD Dr. Belachew has received personal compensation for serving as an employee of Biogen Inc. Dr. Belachew has received stock or an ownership interest from Biogen Inc.
Juha M. Savola, MD,PhD Dr. Savola has received personal compensation for serving as an employee of Teva Pharmaceuticals. Dr. Savola has received intellectual property interests from a discovery or technology relating to health care.
Susan Clawson No disclosure on file
John DeLuca, PhD, ABPP Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. DeLuca has received research support from Biogen.
Derrick Robertson, MD Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Greenwich Biosciences. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mallinckrodt. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PRIME CME. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McVeigh. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mccumber. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goodis. The institution of Dr. Robertson has received research support from Biogen. The institution of Dr. Robertson has received research support from EMD Serono. The institution of Dr. Robertson has received research support from Jansenn. The institution of Dr. Robertson has received research support from Genentech. The institution of Dr. Robertson has received research support from Patient-Centered Outcomes Research Institute. The institution of Dr. Robertson has received research support from Novartis. The institution of Dr. Robertson has received research support from Sanofi Genzyme. The institution of Dr. Robertson has received research support from TG Therapeutics. The institution of Dr. Robertson has received research support from Prime. The institution of Dr. Robertson has received research support from Greenwich Biosciences. The institution of Dr. Robertson has received research support from Atara Biotherapeutics. The institution of Dr. Robertson has received research support from CorEvitas. The institution of Dr. Robertson has received research support from Anokion. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Consortium of Multiple Sclerosis Centers. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America.
Margaret Adler, MD Dr. Adler has nothing to disclose.
Shawniqua Williams Roberson, MD The institution of Dr. Williams Roberson has received research support from the National Institute on Aging. The institution of Dr. Williams Roberson has received research support from Brain & Behavior Research Foundation. Dr. Williams Roberson has received personal compensation in the range of $0-$499 for serving as a Reviewer with the National Institutes of Health.
Ankur Sharma No disclosure on file
Guillermo Povedano, MD No disclosure on file
Nicholas Schwab The institution of Nicholas Schwab has received research support from Biogen. The institution of Nicholas Schwab has received research support from Roche.
Natalia Pessoa Rocha Natalia Pessoa Rocha has nothing to disclose.
Tatiana Zaldivar Vaillant, MD No disclosure on file
Jelena M. Pavlovic, MD, PhD Dr. Pavlovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven.
Rohit Ajay Marawar, MD, FAAN Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. The institution of Dr. Marawar has received research support from Catalyst Pharma.
Peter Pressman, MD The institution of Dr. Pressman has received research support from the Doris Duke Fund to Retain Clinical Scientists . Dr. Pressman has received personal compensation in the range of $100,000-$499,999 for serving as a Associate Professor with University of Colorado School of Medicine.
Courtney Takahashi, MD, FAAN Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sheff Law. Dr. Takahashi has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Weems Hazen Law . Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Keches Law Group. Dr. Takahashi has received personal compensation in the range of $500-$4,999 for serving as a Employee, Founder with Tora Connections. Dr. Takahashi has a non-compensated relationship as a Committee Member with American Academy of Neurology that is relevant to AAN interests or activities.
Francis Michael Gengo, Pharm.D No disclosure on file
Jamie Lynn Adams, MD Dr. Adams has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Adams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Michael J. Fox Foundation. Dr. Adams has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioSensics. The institution of Dr. Adams has received research support from NIH/NINDS. The institution of Dr. Adams has received research support from Biogen. The institution of Dr. Adams has received research support from The Michael J. Fox Foundation. The institution of Dr. Adams has received research support from Critical Path Institute. Dr. Adams has received personal compensation in the range of $500-$4,999 for serving as a KINECT-HD Steering Committee Member with Huntington Study Group. Dr. Adams has received personal compensation in the range of $500-$4,999 for serving as a ORCHESTRA-PD Steering Committee Member with Parkinson Study Group.
Lucas Kipp, MD The institution of Dr. Kipp has received research support from Biogen. The institution of Dr. Kipp has received research support from Genentech.
Giovanna Calandra-Buonaura No disclosure on file
Karen Evankovich No disclosure on file
Pietro Guaraldi, MD, PhD No disclosure on file
Kenneth E. Hill No disclosure on file
Masahisa Katsuno No disclosure on file
Eden R. Martin No disclosure on file
Timothy M. Klein Timothy M. Klein has received personal compensation for serving as an employee of Medical Decision Modeling Inc..
Fumiaki Tanaka No disclosure on file
Naoki Atsuta No disclosure on file
Hitoshi Warita No disclosure on file
Megumi Yamada No disclosure on file
Sung Y. Yu Sung Y. Yu has received personal compensation for serving as an employee of Abbvie. Sung Y. Yu has received stock or an ownership interest from Abbvie.
Gary W. Beecham, PhD The institution of Dr. Beecham has received research support from NIH. The institution of an immediate family member of Dr. Beecham has received research support from NIH.
Shadi Yaghi, MD Dr. Yaghi has nothing to disclose.
Amaal J. Starling, MD, FAAN Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Starling has received personal compensation in the range of $0-$499 for serving as a Consultant for Med-IQ. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Everyday Health. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Miller Medical. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eNeura.
Robert Fishman, MD Dr. Fishman has nothing to disclose.
Omar Jawdat, MD Dr. Jawdat has nothing to disclose.
Sylvia Klineova, MD Dr. Klineova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Klineova has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Klineova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Goran Davidovic, MD No disclosure on file
Regine Buffels, MD Dr. Buffels has nothing to disclose.
Sven G. Meuth Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Maria Naylor, PhD Dr. Naylor has received personal compensation for serving as an employee of Biogen. Dr. Naylor has received stock or an ownership interest from Biogen.
Sara Kate Rostanski, MD Dr. Rostanski has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for individual law firms.
Ashish Pradhan, MD Dr. Pradhan has received personal compensation for serving as an employee of Genentech. Dr. Pradhan has received stock or an ownership interest from Genetech.
Serena Orr, MD The institution of Dr. Orr has received research support from Alberta Children's Hospital Research Institute. The institution of Dr. Orr has received research support from Canadian Institutes of Health Research. The institution of Dr. Orr has received research support from Department of Pediatrics, University of Calgary. Dr. Orr has received publishing royalties from a publication relating to health care. Dr. Orr has a non-compensated relationship as a associate editor with Headache: The Journal of Head and Face Pain that is relevant to AAN interests or activities. Dr. Orr has a non-compensated relationship as a editorial board member with Neurology that is relevant to AAN interests or activities. Dr. Orr has a non-compensated relationship as a editorial board member with American Migraine Foundation that is relevant to AAN interests or activities.
Erica Hailey Parrotta, DO No disclosure on file
Vladimir Coric Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
Nicholas Deconinck Nicholas Deconinck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Nicholas Deconinck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Nicholas Deconinck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for avexis. Nicholas Deconinck has received publishing royalties from a publication relating to health care.
Alexander M. Herrmann No disclosure on file
Hacer Durmus, MD Dr. Durmus has nothing to disclose.
Haruhisa Kato No disclosure on file
Shin Kwak No disclosure on file
Cedric Lamirel No disclosure on file
Eugenio Mercuri Eugenio Mercuri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta, Santhera, PTC, Pfizer, Roche, Biogen, Avexis Novartis, Scholar Rock, Cytokinetics. Eugenio Mercuri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sarepta, Santhera, PTC, Pfizer, Roche, Biogen, Avexis Novartis. The institution of Eugenio Mercuri has received research support from biogen.
Meetu Bhogal, MSc No disclosure on file
Mar Tulinius Mar Tulinius has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for PTC Therapeutics.
Stephen Wharton No disclosure on file
Scott *use 337644 Borland No disclosure on file
Tess Fitzpatrick, MD No disclosure on file
Akira Tamaoka No disclosure on file
Carl Aaron Gold, MD Dr. Gold has received personal compensation for serving as an employee of Stanford University. An immediate family member of Dr. Gold has received personal compensation for serving as an employee of Stanford University.
Janice Chun Yee Wong, MD Dr. Wong has received personal compensation for serving as an employee of Janssen Research & Development. Dr. Wong has received personal compensation for serving as an employee of Biogen. Dr. Wong has stock in Biogen. Dr. Wong has stock in Janssen Research & Development.
Harold Koendgen, MD Dr. Koendgen has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd. Dr. Koendgen has received stock or an ownership interest from F. Hoffmann-La Roche Ltd .
Cumara Barahona O'Carroll, MD, FAAN Dr. O'Carroll has nothing to disclose.
Aysun Soysal, MD Dr. Soysal has nothing to disclose.
Erin Longbrake, MD, PhD, FAAN Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Longbrake has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Longbrake has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Longbrake has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Longbrake has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ACTRIMS. Dr. Longbrake has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Longbrake has received research support from Genentech. The institution of Dr. Longbrake has received research support from Race to Erase MS. The institution of Dr. Longbrake has received research support from NINDS K23. The institution of Dr. Longbrake has received research support from Robert Patterson Leet Trust. The institution of Dr. Longbrake has received research support from Biogen. The institution of Dr. Longbrake has received research support from National MS Society. Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with Department of Defense (CDMRP). Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Programmatic Review with Department of Defense (CDMRP). Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with National Institute of Health .
Michael Haboubi, DO Dr. Haboubi has nothing to disclose.
Tina Mariko Burton, MD Dr. Burton has nothing to disclose.
Prachi Mehndiratta, MD Dr. Mehndiratta has nothing to disclose.
Adam De Havenon, MD Dr. De Havenon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has stock in Certus. Dr. De Havenon has stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Daniel B. Simmons, MD No disclosure on file
Brooke Johnson, DO No disclosure on file
Raghavendra Vasudeva, PhD Dr. Vasudeva has received personal compensation for serving as an employee of Lilly. Dr. Vasudeva has received stock or an ownership interest from Lilly.
Li Liu, MD No disclosure on file
Adeline Su Lyn Ng, MD No disclosure on file
Margaret Sampson No disclosure on file
Timothy Spelman Timothy Spelman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Patrice Whitehead Patrice Whitehead has nothing to disclose.
Blair Wood No disclosure on file
Ichiro Yabe, MD, PhD No disclosure on file
Randip Singh Taneja, MD No disclosure on file
Kristen Fisher, DO Dr. Fisher has nothing to disclose.
Swetha Renati, MD Dr. Renati has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ischemia View. Dr. Renati has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Renati has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Wettermark Keith, LLC. Dr. Renati has received personal compensation in the range of $500-$4,999 for serving as a Speaker with BRAINWEEK.
Alexandra O'Neill Duffy, MD, FAAN Dr. Duffy has nothing to disclose.
Samantha K. Holden, MD, MS, FAAN Dr. Holden has nothing to disclose.
Amit Saindane Amit Saindane has nothing to disclose.
Katleen Wyatt No disclosure on file
Peter Alabi, Sr., MBBS, FMCP Dr. Alabi has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Norvatis.
Wildon Farwell, MD Dr. Farwell has received personal compensation for serving as an employee of Biogen. Dr. Farwell has received stock or an ownership interest from Biogen.
Brin Freund, MD Dr. Freund has nothing to disclose.
Leanne Stunkel, MD Dr. Stunkel has nothing to disclose.
Yuichi Hayashi Yuichi Hayashi has nothing to disclose.
Martin *Use 130037 Weber, MD Martin Weber, MD has nothing to disclose.
Khodayar Farahmand Mr. Farahmand has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc.
Rachel Nolan Ms. Nolan has nothing to disclose.
Christopher Tarolli, MD Dr. Tarolli has received personal compensation for serving as an employee of University of Rochester. The institution of Dr. Tarolli has received research support from Biosensics. The institution of Dr. Tarolli has received research support from National Institutes of Health. The institution of Dr. Tarolli has received research support from Biogen. Dr. Tarolli has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Davis Phinney Foundation. Dr. Tarolli has received personal compensation in the range of $500-$4,999 for serving as a Speaker, Committee Member with American Academy of Neurology. Dr. Tarolli has a non-compensated relationship as a Committee Member with American Academy of Neurology that is relevant to AAN interests or activities.
Blake Newman, MD Dr. Newman has nothing to disclose.
Catherine Miller Catherine Miller has received personal compensation for serving as an employee of Biogen. Catherine Miller has received stock or an ownership interest from Biogen.
Anai Cristina Hamasaki, MD No disclosure on file
Anza Memon, MD, FAAN Dr. Memon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutic .
Christine Jiaying Lo, MD No disclosure on file
Fikret Aysal No disclosure on file
Holmes David No disclosure on file
Harald Hefter No disclosure on file
Jeffrey D. Long Jeffrey Long has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Triplet. Jeffrey Long has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vacinnex. Jeffrey Long has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave. Jeffrey Long has received personal compensation in the range of $0-$499 for serving as a Consultant for PTC. Jeffrey Long has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Jeffrey Long has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Jeffrey Long has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for uniQure. Jeffrey Long has received research support from NIH DSMB.
Yasushi Maeda No disclosure on file
Roberto Poda No disclosure on file
Karina Raimundo No disclosure on file
Verena Ramirez Campos, MD Dr. Ramirez Campos has received personal compensation for serving as an employee of teva.
Ofer Sadan Ofer Sadan has received intellectual property interests from a discovery or technology relating to health care.
Luisa Sambati No disclosure on file
Hidenao Sasaki No disclosure on file
Annette Sauter, PhD Dr. Sauter has received personal compensation for serving as an employee of F.Hoffmann-La Roche .
Hiroshi Sugiyama No disclosure on file
Yoshihisa Takiyama No disclosure on file
Mari Yoshida No disclosure on file
Ahmed Moh'd Yassin, MD Dr. Yassin has nothing to disclose.
Nina Bozinov, MD Dr. Bozinov has nothing to disclose.
Kurt Yuqin Qing, MD Dr. Qing has nothing to disclose.
K. H. Vincent Lau, MD Dr. Lau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. The institution of Dr. Lau has received research support from Amyloidosis Foundation.
WALTER TOLEDO, MD No disclosure on file
Jonathan Ross Galli, MD Dr. Galli has nothing to disclose.
Bill Jacobsen, MD No disclosure on file
Sung Min Cho, DO Dr. Cho has nothing to disclose.
Salman Aljarallah, MD Dr. Aljarallah has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Aljarallah has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Aljarallah has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi Genzyme.
Yara Mikhaeil-Demo, MD The institution of Dr. Mikhaeil-Demo has received research support from DOD/CURE TBI Consortium, Grant W81XWH . The institution of Dr. Mikhaeil-Demo has received research support from Illinois Department of Human Services (IDHS) Grant .
Zain Guduru, MD, FAAN Dr. Guduru has nothing to disclose.
Ahmed Z. Obeidat, MD, PhD Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Celgene. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme . Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon pharmaceuticals . Dr. Obeidat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bio. Dr. Obeidat has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Obeidat has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Alexion. Dr. Obeidat has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Biogen. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Obeidat has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for EMD Serono. Dr. Obeidat has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner life sciences . The institution of Dr. Obeidat has received research support from Neuroscience research center . The institution of Dr. Obeidat has received research support from Research affairs committee. The institution of Dr. Obeidat has received research support from Center for immunology . The institution of Dr. Obeidat has received research support from Parkinson's foundation . The institution of Dr. Obeidat has received research support from Celgene. The institution of Dr. Obeidat has received research support from BMS. The institution of Dr. Obeidat has received research support from EMD Serono. The institution of Dr. Obeidat has received research support from Genentech . The institution of Dr. Obeidat has received research support from Novartis. The institution of Dr. Obeidat has received research support from NMSS and PCORI. The institution of Dr. Obeidat has received research support from Sanofi. The institution of Dr. Obeidat has received research support from Atara Biotherapeutics . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Expert opinion and key opinion leader with MJH life sciences . Dr. Obeidat has received personal compensation in the range of $500-$4,999 for serving as a key opinion leader articles with Medscape. Dr. Obeidat has a non-compensated relationship as a Board member with CMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Advisory Committee Member with ACTRIMS that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Editorial Board Member with IJMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Reviewer Editor with Frontiers Neurology that is relevant to AAN interests or activities.
Michelle P. Lin, MD Dr. Lin has nothing to disclose.
Jan A. Martin, MD Dr. Martin has nothing to disclose.
Eugene L. Scharf, MD The institution of Dr. Scharf has received research support from American Brain Foundation. The institution of Dr. Scharf has received research support from NIH. Dr. Scharf has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Grand Rounds. Dr. Scharf has a non-compensated relationship as a Steering committee with Johnson and Johnson that is relevant to AAN interests or activities.
Alyson Rylie Plecash, MD Dr. Plecash has nothing to disclose.
Andreas Schulte-Mecklenbeck Andreas Schulte-Mecklenbeck has nothing to disclose.
Catharina Groß The institution of Catharina Groß has received research support from Biogen. The institution of Catharina Groß has received research support from Roche.
Daniel Judge No disclosure on file
Erica S. Westphal The institution of Ms. Westphal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for McKesson Coorporation. The institution of Ms. Westphal has received research support from Dent Neurologic Institute.
Anna Fronda No disclosure on file
Giulia Giannini No disclosure on file
Hadas Barkay Hadas Barkay has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Hugh Rickards No disclosure on file
Hung-Ming Wu No disclosure on file
Ingrid Estrada-Bellman No disclosure on file
Janice Robertson Janice Robertson has nothing to disclose.
Atsushi Fujita No disclosure on file
Michelle Rainka, PharmD Dr. Rainka has stock in Abbvie. Dr. Rainka has stock in acadia. Dr. Rainka has stock in alon. Dr. Rainka has stock in biogen. Dr. Rainka has stock in bristol myers squib. Dr. Rainka has stock in eisai. Dr. Rainka has stock in Lilly. Dr. Rainka has stock in novartis. Dr. Rainka has stock in pfizer. Dr. Rainka has stock in roche. Dr. Rainka has stock in Sage. Dr. Rainka has stock in alkermes.
Miguel Guzman No disclosure on file
Naomichi Matsumoto Naomichi Matsumoto has nothing to disclose.
Samuel Bidot Samuel Bidot has nothing to disclose.
Wan-Yu Huang No disclosure on file
Yasushi Iwasaki No disclosure on file
Justin A. Salerian, MD Dr. Salerian has nothing to disclose.
Kenneth Han No disclosure on file
Gloriel Flores-Caban, MD No disclosure on file
Nolan Campbell Nolan Campbell has received personal compensation for serving as an employee of Biogen. Nolan Campbell has stock in Biogen.
John G. Kelsey, MD No disclosure on file
Robin L Avila, PhD Mrs. Avila has received personal compensation for serving as an employee of Biogen. Mrs. Avila has stock in Biogen.
Rocco Joseph Cannistraro, MD No disclosure on file
Tarini Goyal Dr. Goyal has nothing to disclose.
Yin Allison Liu, MD Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Liu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Bhumika Balgobin, MD No disclosure on file
Hao Cheng, MD No disclosure on file
Kamal Shouman, MD The institution of Dr. Shouman has received research support from dysautonomia international.
Carlos Javier Martinez No disclosure on file
Mark A. Whealy, MD No disclosure on file
Catherine Hassett, MD Dr. Hassett has nothing to disclose.
Chuanfu Li No disclosure on file
Kristina Hart, DO No disclosure on file
Daniel J Rader No disclosure on file
Luke Whitmire, PhD No disclosure on file
Horacio Capote, MD No disclosure on file
Mariana Suarez Mariana Suarez has nothing to disclose.
Maria Sol Pacha, 3726 No disclosure on file
Martha Sajatovic, 5110 Martha Sajatovic, 5110 has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alkermes, Otsuka, Janssen, Myriad, Health Analytics, Frontline Medical Communications. The institution of Martha Sajatovic, 5110 has received research support from Nuromate, Otsuka, Alkermes, International Society for Bipolar Disorders (ISBD), National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Patient-Centered Outcomes Research Institute (PCORI). Martha Sajatovic, 5110 has received publishing royalties from a publication relating to health care.
Yorghos Tripodis Yorghos Tripodis, 5406 has nothing to disclose.
Christopher Mooney, 9051 Christopher Mooney, 9051 has nothing to disclose.
Mithilesh Siddu, MD Dr. Siddu has nothing to disclose.
E. Wesley Ely E. Wesley Ely has nothing to disclose.
Chichun Sun, DO Dr. Sun has nothing to disclose.
Elena Rodriguez Martinez No disclosure on file
Fatma Yesim Parman, MD Dr. Parman has nothing to disclose.
Nermin Sirin No disclosure on file
Monica Martinez No disclosure on file
Eric Yang No disclosure on file
Francesco Mignani No disclosure on file
Rachael Wojcik No disclosure on file
Steve Kanes, MD, PhD Dr. Kanes has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Kanes has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Verge Genomics. Dr. Kanes has received intellectual property interests from a discovery or technology relating to health care.
Hannah Castaldi No disclosure on file
Zachary Benjamin Bulwa, MD Dr. Bulwa has nothing to disclose.
Hye-Yun Kim No disclosure on file
Michael Hanna, PhD No disclosure on file
Ifeyinwa Ani-Osheku, MBBS Dr. Ani-Osheku has nothing to disclose.
Mark Anthony Terrelonge, Jr., MD Dr. Terrelonge has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for New England Journal of Medicine.
Xiaoping Ning Ms. Ning has received personal compensation for serving as an employee of Teva Pharmaceutical . Ms. Ning has received personal compensation for serving as an employee of Teva Pharmaceutical.
Jacob Didion, MD No disclosure on file
Jiali Liu No disclosure on file
Nayla Chaijale Nayla Chaijale has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Pei-Ran Ho No disclosure on file
Sarah England, PhD Dr. England has received personal compensation for serving as an employee of Biogen. Dr. England has stock in Biogen.
Ka-Ho Wong The institution of Mr. Wong has received research support from The Sumaira Foundation .
Tobias Derfuss An immediate family member of Tobias Derfuss has received personal compensation for serving as an employee of Novartis. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GeNeuro. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedDay. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Merck. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Roche. An immediate family member of Tobias Derfuss has received stock or an ownership interest from Novartis. The institution of Tobias Derfuss has received research support from Roche. The institution of Tobias Derfuss has received research support from Biogen.
Bernd C. Kieseier, MD Dr. Kieseier has received personal compensation for serving as an employee of Novartis. Dr. Kieseier has stock in Novartis.
Amanda Wilhelm Amanda Wilhelm has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Mason Daniel Dyess, DO Dr. Dyess has nothing to disclose.
Nikita Shukla, MD Dr. Shukla has nothing to disclose.
Chia-Chun Chiang, MD Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene Corporation . The institution of Dr. Chiang has received research support from American Heart Association.
Linda Nguyen, MD, PhD Dr. Nguyen has nothing to disclose.
Feras Akbik, MD Dr. Akbik has nothing to disclose.
Joshua D. Claunch, MD No disclosure on file
Soha Sadeghikhah, MD Dr. Sadeghikhah has nothing to disclose.
Nicola Carlisle, MD No disclosure on file
John Brooks Terry, MD Dr. Terry has nothing to disclose.
Irma Nora Duncan, MD Ms. Duncan has nothing to disclose.
Jakob Mrozewski, MD No disclosure on file
Lydia Robinson Marcus, MD Dr. Marcus has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ragsdale LLC. The institution of Dr. Marcus has received research support from NIAID.
Marco Joseph Russo, MD,PhD No disclosure on file
Rachel J. Gottlieb-Smith, MD Dr. Gottlieb-Smith has received publishing royalties from a publication relating to health care.
Subin Mathew, MD Dr. Mathew has nothing to disclose.
Jose-Alberto Palma, MD, PhD, FAAN Dr. Palma has received personal compensation for serving as an employee of Novartis. Dr. Palma has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Clinical Autonomic Research. The institution of Dr. Palma has received research support from National Institutes of Health. Dr. Palma has received publishing royalties from a publication relating to health care.
Jun Sone, MD, PhD, FAAN No disclosure on file
Jonathan Ratcliff The institution of Dr. Ratcliff has received research support from Nico Corporation. The institution of Dr. Ratcliff has received research support from Sense .
Lilly Fagatele Ms. fagatele has nothing to disclose.
Kiyotaka Nakamagoe No disclosure on file
Koji Oba No disclosure on file
Helen Jessop No disclosure on file
Roland Jimenez No disclosure on file
Jan Kirschner Jan Kirschner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Jan Kirschner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Jan Kirschner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Jan Kirschner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Jan Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genethon. Jan Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Jan Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. The institution of Jan Kirschner has received research support from Biogen. The institution of Jan Kirschner has received research support from Novartis. The institution of Jan Kirschner has received research support from Roche.
Alexandra Kvernland, MD Dr. Kvernland has nothing to disclose.
Jacqueline Leung No disclosure on file
Stephen Marder No disclosure on file
Ayla McCalley No disclosure on file
Oksana Mokliatchouk Oksana Mokliatchouk has received personal compensation for serving as an employee of Biogen. Oksana Mokliatchouk has received stock or an ownership interest from Biogen.
Adeolu Oluwaseun Morawo, MD Dr. Morawo has nothing to disclose.
David Oliveri David Oliveri has received personal compensation for serving as an employee of Genesis Research.
Michael Quirk Michael Quirk has received personal compensation for serving as an employee of Sage Therapeutics. Michael Quirk has received stock or an ownership interest from Sage Therapeutics.
Leslie Lundt Leslie Lundt has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc.
John Snowden No disclosure on file
Li Zeng No disclosure on file
Tomasz Zielinski No disclosure on file
Lidia Binela Lara Lezama No disclosure on file
Edward J. Wild, PhD, MBBS, MRCP Dr. Wild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon Biosciences. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teitur Trophics. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Remix Therapeutics. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman La Roche. Dr. Wild has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Triplet Therapeutics. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vico Therapeutics. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spark Therapeutics. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Wild has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for HDBuzz (a registered non-profit). The institution of Dr. Wild has received research support from CHDI Foundation (non-profit). The institution of Dr. Wild has received research support from Hoffman La Roche Ltd.
Sushant Puri, MBBS Dr. Puri has nothing to disclose.
Stephanie Licata Stephanie Licata has received personal compensation for serving as an employee of Biogen. Stephanie Licata has received stock or an ownership interest from Biogen.
Lisanne Korn No disclosure on file
Loren Friedman No disclosure on file
James Doherty, PhD Dr. Doherty has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Doherty has received stock or an ownership interest from Sage Therapeutics.
Giancarlo *USE ID 014384 Comi Giancarlo *USE ID 014384 Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Giancarlo *USE ID 014384 Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Giancarlo *USE ID 014384 Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Giancarlo *USE ID 014384 Comi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Giancarlo *USE ID 014384 Comi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rewind.
Luis Hernandez-Echebarria No disclosure on file
Saurav Das, MD Dr. Das has nothing to disclose.
Anusha Boyanpally, MBBS No disclosure on file
Dev Mehta, DO Dr. Mehta has nothing to disclose.
Anuj Patel, MD Dr. Patel has nothing to disclose.
Brittany Elyce Lachance, MD No disclosure on file
Ibrahim Migdady, MD Dr. Migdady has nothing to disclose.
Sam Hooshmand, DO Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech/Roche. Dr. Hooshmand has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi .
Melanie Braun, MD Dr. Braun has nothing to disclose.
Martha Robinson, MD Dr. Robinson has nothing to disclose.
Raffaella Umeton, MD Dr. Umeton has nothing to disclose.
Swathy Chandrashekhar, MD Dr. Chandrashekhar has received publishing royalties from a publication relating to health care.
Bryce Buchowicz, MD No disclosure on file
Daniela Arantxa Pimentel Maldonado, MD, MSCR Dr. Pimentel Maldonado has nothing to disclose.
Xiyan Yi, MD Dr. Yi has nothing to disclose.
Anne Tebo Anne Tebo has received personal compensation for serving as an employee of RenalytixAI. The institution of Anne Tebo has received research support from Euroimmun US and Kronus Inc US.
Thomas Raymond Haven, PhD Dr. Haven has nothing to disclose.
Ko-Hung Liu No disclosure on file
Ya-Ping Chen No disclosure on file
Ting-Yu Chen No disclosure on file
Claudia Janoschka Claudia Janoschka has nothing to disclose.
Shankung Lin No disclosure on file
Sara Samadzadeh No disclosure on file
Cynthia C. Jones, PhD Dr. Jones has received personal compensation for serving as an employee of Biogen. Dr. Jones has received stock or an ownership interest from Biogen.
Farhan Bhanji No disclosure on file
Koji Abe No disclosure on file
John J. Chen John J. Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. John J. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. John J. Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon.
Christopher Leon Guerrero No disclosure on file
Eduard Shaykhinurov No disclosure on file
Abdulrahman Bukhari, MBBS Dr. Bukhari has nothing to disclose.
Antony Chu No disclosure on file
Ishir Bhan No disclosure on file
Adriana Naomi Sari, MD Dr. Sari has nothing to disclose.
Traci Aladeen, PharmD Dr. Aladeen has nothing to disclose.
Damon Philip Cardenas, PhD No disclosure on file
Majd mo’adi No disclosure on file
Ahmad al Omari No disclosure on file
Michelle A. Farrar Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Michelle A. Farrar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Janet Ford Janet Ford has received personal compensation for serving as an employee of Eli Lilly and Company . Janet Ford has received stock or an ownership interest from Eli Lilly and Company .
Arthur J Labovitz No disclosure on file
Akihiro Kawata No disclosure on file
Peng Sun Peng Sun has received personal compensation for serving as an employee of Biogen . Peng Sun has received stock or an ownership interest from Biogen.
Alazar Ayele Alazar Ayele has nothing to disclose.
Wei Wei Wei Wei has received personal compensation for serving as an employee of Hoffmann -La Roche. Wei Wei has received stock or an ownership interest from Hoffmann-La Roche.
Liang Zhu Liang Zhu has nothing to disclose.
Olivia Gardner, MD, PhD No disclosure on file
Carlos Alves Batista, MD No disclosure on file
Petra Dirks Petra Dirks has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd .
Mark Kenneth Lukewich No disclosure on file
Benson Chen, MBChB Dr. Chen has nothing to disclose.
Jakub Jedynak Jakub Jedynak has received personal compensation for serving as an employee of Lilly. Jakub Jedynak has received stock or an ownership interest from Lilly.
Matthew Schlenker No disclosure on file
Max Novak No disclosure on file
Meg M Parker No disclosure on file
Merisa Kline No disclosure on file
Michael G Fradley No disclosure on file
Michael Kelly Michael Kelly has nothing to disclose.
Min Ky Kim No disclosure on file
Mizuho Asada Mizuho Asada has nothing to disclose.
Moo-Seok Park No disclosure on file
Morgan Reynolds No disclosure on file
Charlie Conway Charlie Conway has received personal compensation for serving as an employee of Biohaven Pharmaceuticals Inc. Charlie Conway has received stock or an ownership interest from Biohaven Pharmaceuticals.
Naghmeh Ghazaleh No disclosure on file
Nancy Ramia Nancy Ramia has received personal compensation for serving as an employee of Biogen.
Natalia Hofmann No disclosure on file
Natalie Castro No disclosure on file
Nathalie Strazielle No disclosure on file
Nathan Muntz No disclosure on file
NEALS Clinical Studies Group NEALS Clinical Studies Group has nothing to disclose.
Nhi Tran Nhi Tran has nothing to disclose.
Nikhil Panda No disclosure on file
Norihiko Inoue No disclosure on file
Norma Lopez Norma Lopez has nothing to disclose.
Omar Telfah No disclosure on file
Patricia Kolbe No disclosure on file
Patricia Rosalia Ancer Rodriguez No disclosure on file
Peter Pham No disclosure on file
Pratik P Pandharipande No disclosure on file
Stacy Finkbeiner No disclosure on file
Kathryn Giles Kathryn Giles has stock in Synderdisc. The institution of Kathryn Giles has received research support from Biogen.
Rachael Swisher No disclosure on file
Rachel Perez-Lalana No disclosure on file
Randall Starling Randall Starling has nothing to disclose.
Richard Houghton No disclosure on file
Licinio Manuel Craveiro, MD, PhD Dr. Craveiro has received personal compensation for serving as an employee of Hoffmann La-Roche. Dr. Craveiro has received stock or an ownership interest from Hoffmann La-Roche.
Sahil Mann, MD No disclosure on file
Samantha Hentosh Miss Hentosh has nothing to disclose.
Samuel Buckland No disclosure on file
Sandrine Blondel No disclosure on file
Sasha Mansukhani No disclosure on file
Satomi Mitsuhashi No disclosure on file
Boris Kandinov No disclosure on file
Scott M Damrauer No disclosure on file
Thomas James Williams, MD Dr. Williams has nothing to disclose.
Sherida Padilla No disclosure on file
Joyutpal Das, MBBS Dr. Das has nothing to disclose.
Jessie Jacobson, DO Dr. Jacobson has nothing to disclose.
Ruchi Dhyani, MD No disclosure on file
Christina Yuen, MD No disclosure on file
Shweta Varade, MD Dr. Varade has nothing to disclose.
Abinayaa Purushothaman Ravichandran, MD Dr. Purushothaman Ravichandran has nothing to disclose.
Tracey Huijun Fan, DO Dr. Fan has nothing to disclose.
Brandon Giglio, MD Dr. Giglio has nothing to disclose.
Bahareh Sianati, MD No disclosure on file
Varun Kumar Pala, MD Dr. Pala has nothing to disclose.
Shadi Milani, DO Dr. Milani has nothing to disclose.
Maryam Hosseini, MD Dr. Hosseini has nothing to disclose.
Sigui Li Sigui Li has received personal compensation for serving as an employee of SAGE Therapeutics.
Robert Craig Coppola, DO Dr. Coppola has nothing to disclose.
Simone Konig No disclosure on file
sofia farina No disclosure on file
Andrea Ines Ciplea An immediate family member of Ms. Ciplea has received personal compensation for serving as an employee of Astra Zeneca. Ms. Ciplea has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Bayer Healthcare. Ms. Ciplea has received personal compensation in the range of $0-$499 for serving as a payment of travel-related expenses with Novartis. Ms. Ciplea has received personal compensation in the range of $0-$499 for serving as a payment of congress fees with Teva.
Saba Sari Mohidat, Jr., MD Dr. Mohadat has nothing to disclose.
Mohamad Alkhouli, MD No disclosure on file
Almer Mendoza No disclosure on file
Amy Braden No disclosure on file
Angie Shoen No disclosure on file
Reza Arsanjani No disclosure on file
Astrubal Arias No disclosure on file
Atul Singla No disclosure on file
Gordon Graham No disclosure on file
Dorene Balmer No disclosure on file
Basheer Khassawneh Basheer Khassawneh has nothing to disclose.
Benoit Hijazi No disclosure on file
Brandon Farley No disclosure on file
Brenda T Pun No disclosure on file
Bucky K Lozier Bucky K Lozier has nothing to disclose.
Barbette Weimer-Elder No disclosure on file
Christine Vande Velde Christine Vande Velde has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BridgeBio. Christine Vande Velde has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT Pharma. Christine Vande Velde has received research support from ALS Canada. Christine Vande Velde has received research support from Target ALS . Christine Vande Velde has received research support from Muscular Dystrophy Association. Christine Vande Velde has received research support from ALS Association.
Chieh-Ju *Use 388608 Chao No disclosure on file
Chien-Ju Lin Chien-Ju Lin has nothing to disclose.
Matthew Kay No disclosure on file
Christina Hanania, MBBS No disclosure on file
Christopher Grow No disclosure on file
Anthony J. Griswold, PhD Dr. Griswold has received research support from National Institutes of Health.
Goldie S. Byrd Goldie S. Byrd has nothing to disclose.
Cindy Shen No disclosure on file
Claire Magnussen No disclosure on file
David Clemow No disclosure on file
Clive Pullinger No disclosure on file
Courtney Wong No disclosure on file
Carolina M Torres No disclosure on file
Cynthia Lopez-Botello Cynthia Lopez-Botello has nothing to disclose.
Dan Wang No disclosure on file
Jose Davila No disclosure on file
Natalie Chan-Lam No disclosure on file
David Erbe David Erbe has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. David Erbe has received stock or an ownership interest from Alnylam Pharmaceuticals. David Erbe has received intellectual property interests from a discovery or technology relating to health care.
Yara Abukariem No disclosure on file
Toshia Myers Toshia Myers has received personal compensation for serving as an employee of TrueNorth Health Foundation.
Yulian Duan No disclosure on file
Derek Van Booven No disclosure on file
Gaurav Sharma No disclosure on file
Ericha Franey Ericha Franey has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc.. Ericha Franey has received stock or an ownership interest from Ericha Franey.
Saleh Abbas No disclosure on file
Alex Exuzides Alex Exuzides has nothing to disclose.
Ezri Yuen No disclosure on file
Federico Oppi No disclosure on file
Filipe Branco Filipe Branco has received personal compensation for serving as an employee of Biogen. Filipe Branco has received stock or an ownership interest from Biogen.
Franco Santajuliana No disclosure on file
Paul Friedman Paul Friedman has received intellectual property interests from a discovery or technology relating to health care. Paul Friedman has received intellectual property interests from a discovery or technology relating to health care. Paul Friedman has received intellectual property interests from a discovery or technology relating to health care.
Greg Hinkle No disclosure on file
Gianmaria Asioli No disclosure on file
Atta Gill No disclosure on file
Giulia Gambino Giulia Gambino has nothing to disclose.
Yali Gui No disclosure on file
Haitao Tu No disclosure on file
Beatriz *use 331976 Chávez No disclosure on file
Stjepana Kovac No disclosure on file
Peyton Meyer No disclosure on file
William Bush No disclosure on file
Marcus Vinicius Rocha Pinto, MD Dr. Pinto has nothing to disclose.
Andrew D. Chang, MS No disclosure on file
Christopher Song No disclosure on file
Hongjuan Liu Hongjuan Liu has received personal compensation for serving as an employee of BMS.
Elizabeth Cunningham Elizabeth Bachman has nothing to disclose.
Shivani Naik, MD Dr. Naik has nothing to disclose.
Morgan Brand No disclosure on file
Julie Selkirk No disclosure on file
Chelsey Mcpheeters, PharmD No disclosure on file
Ignacio Albornoz No disclosure on file
Ilaria Cani, MD No disclosure on file
Marie Liebmann No disclosure on file
Masatoshi Inden No disclosure on file
Irina Movseyan No disclosure on file
Richard Foster Richard Foster has received personal compensation for serving as an employee of Biogen.
Su-Yeon Hwang No disclosure on file
Janice Hanson No disclosure on file
Jason Berlin No disclosure on file
Javier Duarte Bravo No disclosure on file
Jayne Yi Tan No disclosure on file
John DelGaudio No disclosure on file
Jonathan Dupre No disclosure on file
Jean-Francois Ghersi-Egea No disclosure on file
Jheison Giraldo No disclosure on file
Jianmei Wang No disclosure on file
James Louie No disclosure on file
Jonathan Micieli No disclosure on file
Takiyah Starks No disclosure on file
Larry D. Adams Larry D. Adams has nothing to disclose.
Michael L. Cuccaro Michael L. Cuccaro has nothing to disclose.
Joseph Picone No disclosure on file
Joseph Weldon Furr, Jr., MD No disclosure on file
Takuya Kawahara No disclosure on file
Julius Eggebrecht Julius Eggebrecht has received personal compensation for serving as an employee of Roche Pharma AG. Julius Eggebrecht has received stock or an ownership interest from Roche .
Lisa Kay Peterson, PhD The institution of Dr. Peterson has received research support from Kronus.
Kazuhiro Ishii No disclosure on file
Katayoun Fomani No disclosure on file
Kiyohide Fushimi No disclosure on file
Jeong-Hoon Kim No disclosure on file
Kimberly Davis No disclosure on file
Klara Keine No disclosure on file
Arun Kaul No disclosure on file
Timothy Wood No disclosure on file
Debra Pugh No disclosure on file
Susan Humphrey-Murto No disclosure on file
Kate Paget No disclosure on file
Kristen Lucas Kristen Lucas has nothing to disclose.
Jacqueline Meaney No disclosure on file
Hisaka Kurita No disclosure on file
Kevin Zuber No disclosure on file
Padmavati Rajdatta Eksambe, MD Dr. Eksambe has nothing to disclose.
Theo Kruschel No disclosure on file
Thomas Munger No disclosure on file
Tomoko Saito No disclosure on file
Vincent Teo No disclosure on file
Vinit Shah No disclosure on file
Vuslat Yilmaz Vuslat Yilmaz has nothing to disclose.
Weng Khong Lim No disclosure on file
Jorg Windsheimer Jorg Windsheimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Biogen,BMS,Janssen,Roche,Hexal. Jorg Windsheimer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen,Teva,BMS.
Scott Schobel Scott Schobel has received personal compensation for serving as an employee of F. Hoffman-La Roche Ltd.
Xiaojin Zhang No disclosure on file
Xiaoqian Fang Xiaoqian Fang has nothing to disclose.
Chineze Nwebube, MD Ms. Nwebube has nothing to disclose.
Yodeisy Ferrer No disclosure on file
Yoshihiko Okubo No disclosure on file
Yuan Zhao Yuan Zhao has received personal compensation for serving as an employee of Biogen. Yuan Zhao has received stock or an ownership interest from Biogen. Yuan Zhao has received intellectual property interests from a discovery or technology relating to health care.
Yutaka Matsuyama No disclosure on file
Zhengnian Ding No disclosure on file
Alison Deighton Alison Deighton has nothing to disclose.
Christopher Jensen, PharmD Dr. Jensen has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Jensen has stock in Biohaven Pharmaceuticals.
Alexandra Thiry Alexandra Thiry has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Alexandra Thiry has received stock or an ownership interest from Biohaven Pharmaceuticals.
Mehnaaz Ali, MBBS No disclosure on file
Andrea Ivans Andrea Ivans has received personal compensation for serving as an employee of Biohaven Pharmaceuticals.
Demilade Adedinsewo An immediate family member of Demilade Adedinsewo has received personal compensation for serving as an employee of Apple Inc. The institution of Demilade Adedinsewo has received research support from NIH. The institution of Demilade Adedinsewo has received research support from Miami Heart Research Institute.
Ana Paula Costa No disclosure on file
Austin L. Hand Austin L. Hand has received personal compensation for serving as an employee of IQVIA. Austin L. Hand has received personal compensation for serving as an employee of Corcept Therapeutics .
Belisa Lopes Alvares No disclosure on file
Beth Morris Beth Morris has received personal compensation for serving as an employee of Biohaven Pharmaceuticals Inc. Beth Morris has received stock or an ownership interest from Biohaven Pharmaceuticals Inc.
Cory Hultman No disclosure on file
Katherine Sommer Katherine Sommer has received personal compensation for serving as an employee of AbbVie. Katherine Sommer has stock in AbbVie.
David Nguyen No disclosure on file
Debora RMF Cunha No disclosure on file
Denisse Grace Martinez Roque, Jr. Miss Martinez Roque has nothing to disclose.
Abdel-Hameed Al-Mistarehi Mr. Al-Mistarehi has nothing to disclose.
Silky Adya No disclosure on file
Emerson de Paula Santos No disclosure on file
Evan Popoff Evan Popoff has nothing to disclose.
Felix Marsh-Wakefield No disclosure on file
Helen McGuire No disclosure on file
Hollis Lin Hollis Lin has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Hollis Lin has received stock or an ownership interest from Alnylam Pharmaceuticals.
Ian Finkelstein, MD Dr. Finkelstein has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allergan. Dr. Finkelstein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Aralez. Dr. Finkelstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Finkelstein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Finkelstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Finkelstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Finkelstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Finkelstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aralez. Dr. Finkelstein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Allergan. Dr. Finkelstein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Finkelstein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Aralez.
Irena Webster No disclosure on file
Holland Detke Holland Detke has received personal compensation for serving as an employee of Eli Lilly and Company. Holland Detke has received stock or an ownership interest from Eli Lilly and Company.
Jorge WJ Bizzi No disclosure on file
Janet Kandrevas No disclosure on file
Jonathan de Courcy Jonathan de Courcy has nothing to disclose.
Joseph Stringfellow Joseph Stringfellow has nothing to disclose.
Kara Hamilton-Nelson Kara Hamilton-Nelson has nothing to disclose.
Karissa Johnston Karissa Johnston has nothing to disclose.
Lara Fahmy, M.Sc. Ms. Fahmy has nothing to disclose.
Richard W. Hughes, MBBS Dr. Hughes has received personal compensation for serving as an employee of Biogen. Dr. Hughes has stock in Biogen.
Leah Hoffman No disclosure on file
Diego Fernandez-Vial Linda Harris has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Linda Harris has received stock or an ownership interest from Biohaven Pharmaceuticals.
Matthew Leyden No disclosure on file
Elyse Stock Elyse Stock has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. An immediate family member of Elyse Stock has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Biohaven Pharmaceuticals. An immediate family member of Elyse Stock has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Flagship Pioneering Management. An immediate family member of Elyse Stock has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol-Myers Squibb. An immediate family member of Elyse Stock has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Optinose. An immediate family member of Elyse Stock has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abpro. An immediate family member of Elyse Stock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Adagio. Elyse Stock has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Biohaven Pharmaceuticals. Elyse Stock has received stock or an ownership interest from Biohaven Pharmaceuticals. An immediate family member of Elyse Stock has received stock or an ownership interest from BIohaven Pharmaceuticals.
Mitchell Wilson, MD Dr. Wilson has nothing to disclose.
Chantal Nifle No disclosure on file
Mugdha Jaitpal No disclosure on file
Montserrat Vera Llonch Montserrat Vera Llonch has received personal compensation for serving as an employee of Akcea. Montserrat Vera Llonch has received stock or an ownership interest from Akcea.
Nathan Ching No disclosure on file
Ayse Nur Ozdag Acarli Ayse Nur Ozdag Acarli has nothing to disclose.
Paula M. Hauck Paula M Hauck has received personal compensation for serving as an employee of Eli Lilly and Company.
Parisa Dabirvaziri No disclosure on file
Sheena Singh No disclosure on file
Pierre Juillard No disclosure on file
Peter Macintosh No disclosure on file
Paul Nioi Paul Nioi has received personal compensation for serving as an employee of Alnylam. Paul Nioi has received stock or an ownership interest from Alnylam.
Rani *use 291581 Vasireddy, MD No disclosure on file
Fnu *Use 393206 Sameeullah No disclosure on file
Scott N Byrne No disclosure on file
Diego Silva Diego Silva has received personal compensation for serving as an employee of BMS. Diego Silva has received stock or an ownership interest from BMS.
Shivani Kapadia Shivani Kapadia has received personal compensation for serving as an employee of Biogen. Shivani Kapadia has received stock or an ownership interest from Biogen.
Stephen F. Thompson Stephen Thompson has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Simina Ticau Simina Ticau has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Simina Ticau has received stock or an ownership interest from Alnylan Pharmaceuticals.
Susanne Clinch Susanne Clinch has received personal compensation for serving as an employee of Roche Products Limited. Susanne Clinch has stock in F.Hoffman-La Roche Ltd.
Ruoding Tan No disclosure on file
Thomas Ashhurst No disclosure on file
Tu My To Tu My To has received personal compensation for serving as an employee of Genentech. Tu My To has received stock or an ownership interest from Genentech.
Umang Ondhia No disclosure on file
Vladimir *use 173444 Coric No disclosure on file
Grace Yan No disclosure on file
Michelle Finnegan Michelle Finnegan has received personal compensation for serving as an employee of AbbVie.
Kaifeng Lu Kaifeng Lu has received personal compensation for serving as an employee of AbbVie. Kaifeng Lu has stock in AbbVie. Kaifeng Lu has stock in Beigene.
Armin Szegedi No disclosure on file
Kayoko Saito, MD, PhD Dr. Saito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapies, Inc./Novartis. Dr. Saito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Saito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai (Roche). Dr. Saito has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis Gene Therapies, Inc./Novartis. Dr. Saito has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Chugai (Roche). The institution of Dr. Saito has received research support from Biogen.
Fransisca Indraswari, MD Dr. Indraswari has nothing to disclose.
Eric Tamrazian, MD Dr. Tamrazian has nothing to disclose.
Matthew Hiller, MD No disclosure on file
Erin Barnes, MD Dr. Barnes has nothing to disclose.
Jonathan Yexian Lai, MBBS No disclosure on file
Yash Shah, MD, MBBS, MPH Dr. Shah has nothing to disclose.
Meghana Kinariwala, MD Dr. Srinivas has nothing to disclose.
Justin Rosati, MD Dr. Rosati has nothing to disclose.
Houman Khosravani, MD, PhD Dr. Khosravani has nothing to disclose.
Sara Rubenstein, MD Dr. Rubenstein has nothing to disclose.
Destiny Lee Marquez, MD Dr. Marquez has nothing to disclose.
Elle Wade, MD No disclosure on file
Rebecca T. Hsu, MD Dr. Hsu has nothing to disclose.
Maria Claudia Manieri No disclosure on file
Jihad Aljabban No disclosure on file
Michael Atalay No disclosure on file
Simin Baygani Simin Baygani has received personal compensation for serving as an employee of Eil Lilly & Company. Simin Baygani has received stock or an ownership interest from Eli Lilly & Company.
Guy Boudreau No disclosure on file
Arman Cakar Arman Cakar has nothing to disclose.
Sergio Andres Castillo Torres No disclosure on file
Michael Curtis No disclosure on file
Luiza de Castro No disclosure on file
Molly Elson No disclosure on file
John Furey Mr. Furey has nothing to disclose.
Corrie Graboski Corrie Graboski has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/AbbVie. Corrie Graboski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Corrie Graboski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NuvoPharm. Corrie Graboski has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan/AbbVie. Corrie Graboski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lily. Corrie Graboski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Corrie Graboski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NuvoPharm. Corrie Graboski has received research support from Amgen/Novartis. The institution of Corrie Graboski has received research support from Allergan/Abbvie.
Georges Grau No disclosure on file
Dexter Hadley No disclosure on file
Peter Wijeratne No disclosure on file
Madeline Merkel Madeline Merkel has received personal compensation for serving as an employee of Alnylam Pharmaceuticals.
Kengo Maeda No disclosure on file
Himani Khatter Ms. Khatter has nothing to disclose.
Bharat Singh No disclosure on file
May Ong-Lam The institution of May Ong-Lam has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck .
Dylan Trundell Dylan Trundell has received personal compensation for serving as an employee of Roche Products Ltd. Dylan Trundell has received stock or an ownership interest from Roche Products Ltd.
Jost Leemhuis Jost Leemhuis has received personal compensation for serving as an employee of Roche Pharma AG.
Stefanie Hieke-Schulz No disclosure on file
Kalpesh Prajapati Kalpesh Prajapati has nothing to disclose.
Sylvia Bereknyei Merrell No disclosure on file
Leena Raza No disclosure on file
Lee Smolen Lee Smolen has received personal compensation for serving as an employee of Medical Decision Modeling Inc..
Chuck Yonan Chuck Yonan has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc.
Emma Waddell Emma Waddell has nothing to disclose.
Kelsey Spear No disclosure on file
David Mitten No disclosure on file
Ray Su No disclosure on file
Gloria Lara-Ferandez No disclosure on file
Ryka Sehgal, MD Ms. Sehgal has nothing to disclose.
Tatenda Mahlanza No disclosure on file
Peter Pollak No disclosure on file
Leonardo Cordenonzzi No disclosure on file
Marino Bianchini No disclosure on file
Karthik Dinesh No disclosure on file
Jessica Greger, PharmD No disclosure on file
Nicholas Gross, MS Nicholas Gross, MS has nothing to disclose.
Gilbert J. L'Italien Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has stock in biohaven pharmaceuticals.
Andrew Lovley Andrew Lovley has received personal compensation for serving as an employee of QualityMetric.
Giuseppe Palermo Giuseppe Palermo has received personal compensation for serving as an employee of F. Hoffman-La RocheLtd..
Michael Pollock No disclosure on file
Lawrence *use 118531 Severt No disclosure on file
Arshdeep Singh, Jr., MBBS No disclosure on file
Virginia L. Stauffer Virginia L. Stauffer has received personal compensation for serving as an employee of Eli Lilly and Company. Virginia L. Stauffer has received stock or an ownership interest from Eli Lilly and company.
Ikuko Takahashi No disclosure on file
Maria Wieman, MPH No disclosure on file
Aaron Yarlas, PhD Dr. Yarlas has received personal compensation for serving as an employee of Ionis Pharmaceuticals. Dr. Yarlas has stock in Ionis Pharmaceuticals.
Eris Bame No disclosure on file
Dongxia Xing No disclosure on file
Eric Zhou, MD Mr. Zhou has nothing to disclose.
Aaron Koenig Aaron Koenig has received personal compensation for serving as an employee of Sage Therapeutics.
Hans Frykman, MD, PhD, FRCPC No disclosure on file
Ronghua Yang, PhD No disclosure on file
Brent Jacobus, II, MD Dr. Jacobus has nothing to disclose.
Cecilia Peterson An immediate family member of Ms. Peterson has received personal compensation for serving as an employee of 100Plus.
Takahisa Mikami, MD Dr. Mikami has nothing to disclose.
Karina A. Gonzalez Otarula, MD Dr. Gonzalez Otarula has nothing to disclose.
Asif *use 295903 Hilmi, MD No disclosure on file
Marissa Catherine Ilardi, MD Dr. Ilardi has nothing to disclose.
Daniela Lozano, MD Ms. Lozano has nothing to disclose.
Vineeth Jaison, MD, MBBS, DM No disclosure on file
Najiyah Salwa No disclosure on file
Ehab Yaser Khaled Harahsheh, MBBS Dr. Harahsheh has nothing to disclose.